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ABSTRACT 
Metabolic Regulation and Cryotolerance of In Vitro-Produced Holstein Embryos  
Melissa Ann Roberts 
 
In vitro production and transfer of embryos has become a common practice within 
the dairy industry to efficiently breed superior animals and meet the consumption demand 
of the growing population. Cyropreservation is necessary for the application of 
commercialized embryo transfer, however, in vitro-produced embryos show morphological 
and physiological defects which negatively impact their ability to withstand 
cryopreservation in comparison to their in vivo counterparts. These artifacts result from 
culture conditions that cause stress to the embryo during development, leading to an 
accumulation of intracellular lipids, mitochondrial dysfunction, and ultimately poor ability 
to withstand freezing and thawing. The objective of these studies was to examine the 
effects of various metabolic regulators on the viability and cryotolerance of in vitro-
produced embryos. Pilot studies revealed that evaluating early (stage 6) versus late (stage 
7) blastocysts did not affect the trend seen in results, nor did culturing embryos in 
continuous versus sequential media. From the main experiment performed, it was 
concluded that a combination of metabolic regulators decreased lipid content, improved 
cryopreservation survival, and lowered the percentage of apoptotic cells present after 
thawing. Conditioned media increased the blastocyst percentage, but did not produce 
superior quality embryos as measured by cryotolerance. Research concerning the 
metabolic needs of the preimplantation embryo must continue to determine more relevant 
markers of embryo quality in vitro.  
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Chapter 1. Introduction 
1.1 History and context 
With a growing human population and limited supply of natural resources, the 
efficiency of milk production in the dairy industry becomes important. Genetic selection 
and breeding techniques using assisted reproductive technologies (ART) allow for the top 
producing cows to be efficiently bred, yielding an average of 6 to 7 viable embryos per 
cycle after superovulation, oocyte retrieval, and in vitro-fertilization (IVF) (Perry, 2014). 
These embryos can be transferred to recipients with an expected pregnancy rate of 50-
60%, and the process can be repeated with each cycle (Hasler, 2014). Using ART, multiple 
pregnancies per year can be generated from one superior genetic combination, compared 
to the typical 1 to 2 calves that a cow can naturally deliver per year. Therefore, fewer cows 
are needed to produce the same amount of milk, cutting down on feed costs, water 
requirements, and minimizing the carbon footprint of the dairy industry. These outcomes 
tackle some of the most pressing issues in the agricultural industry of the United States.  
The downside of selective breeding is that primary focus has been placed on 
breeding for milk production rather than fertility, creating a subfertile population of dairy 
cattle (Moore & Thatcher, 2006). This subfertility is characterized by low pregnancy rates 
and high embryonic mortality, with a final conception rate of only 28% per cycle in lactating 
dairy cows (Moore & Thatcher, 2006). Multiple explanations and solutions for this 
occurrence have been proposed, but what has been made clear is that the dairy industry 
requires ART not only for genetic selection, but also for successful pregnancy outcomes. 
As research reveals the dynamics behind the reproductive cycle and early embryonic 
development in the cow, manipulation of these processes becomes practical.  
Over the past 40 years, the practice of embryo transfer in dairy cattle has 
transformed from an experimental procedure into a reliable technique that serves as the 
basis for thousands of commercial businesses worldwide (Hasler, 2014). The success of 
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embryo transfer brought about the advent of in vitro-produced (IVP) embryos, generated 
from oocytes that undergo IVF. These IVP embryos spend their beginning phase of life in 
an artificial setting aimed at mimicking the natural environment of a cow. The goal is to 
culture embryos until they develop to a stage in which they can be transferred non-
surgically into the uterus of a recipient, which is typically 7 days after fertilization.  
Techniques such as superovulation and embryo transfer, in vitro production of 
embryos, fertilization using sexed semen, cloning, transgenesis, preimplantation genetic 
diagnostics, and gamete storage have arisen as the forefront assisted reproductive 
technologies (Moore & Thatcher, 2006). The first live calf was produced by IVF in 1981, 
and the first live calf produced from in vitro-maturation (IVM) of an oocyte followed by IVF 
was born in 1986 (Moore & Thatcher, 2006). IVF and embryo transfer has benefited 
agricultural business by allowing for the import and export of embryos between countries 
without the transmission of infectious disease (Mapletoft, 2013). Embryo production by 
IVF reached an all-time high in 2013, resulting in the transfer of over 400,000 embryos 
(Perry, 2014), and accounting for 42% of the total number of bovine embryos (in vitro plus 
in vivo) produced that year (Blondin, 2015). The future of embryo transfer holds the 
potential of genomic testing that will provide a selective means of transfer and lead to a 
more technologically sophisticated industry (Blondin, 2015; Hasler, 2014).  
Despite the promising improvement of embryo culture and transfer on pregnancy 
rates of herds with low fertility, there are limitations that have stifled its progress. It is widely 
agreed that in vitro culture (IVC) of embryos does not accurately mimic the natural 
environment of the oviduct and uterus of a cow during pregnancy (Absalón-Medina, Butler, 
& Gilbert, 2014; J. G. Thompson, 2000). Additionally, aside from the increased cost of 
ART as compared to standard artificial insemination (AI), the sub-optimal culture 
conditions of IVC have led to decreased fetal survival and occasional abnormalities (J. G. 
Thompson, 2000). One of the most noted abnormalities is known as “large offspring 
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syndrome,” and was linked to the use of serum in embryo culture media (Young, Sinclair, 
& Wilmut, 1998). Furthermore, IVP bovine embryos have morphological, cellular, and 
physiological differences that impair their ability to withstand cryopreservation (Fair et al., 
2001). These differences highlight the need for improvement of the IVC process to make 
IVP embryos more similar to their in vivo counterparts. 
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1.2 Cryopreservation  
Successful cryopreservation is essential for the use of IVP embryos in a 
commercial setting because it allows for them to be stored, shipped, and transferred to a 
recipient at the most opportune time (Fair et al., 2001; M. Sudano, Paschoal, & Maziero, 
2013). Beyond the commercial application of cryopreservation, this technology also 
provides a way to prevent permanent germplasm losses in the cattle population 
(Dobrinsky, 2002). In the early 2000s, foot-and-mouth disease outbreaks occurred in the 
U.S. and the U.K. then quickly spread to other parts of Europe, leading to the slaughter of 
over 4 million cows in the U.K. in an attempt to control the outbreak (Dobrinsky, 2002). By 
retaining a store of cryopreserved semen, oocytes, and embryos, the loss of these 
germplasm resources can be avoided in the event of disease outbreak or other 
catastrophes. 
The most common method of cryopreservation is a slow freezing procedure which 
permits direct transfer of embryos into a recipient as the thawing process can occur in 
utero. This technique was first performed with a mouse embryo in 1972 (Whittingham, 
Leibo, & Mazur, 1972), then shortly after with a bovine embryo in 1973 (Wilmut & Rowson, 
1973). In this procedure, the embryo is exposed to a low concentration (1.5M) of a 
permeating cryoprotectant, such as ethylene glycol or glycerol, then cooled to between -
30 and -65⁰C at a rate of 0.3-0.5⁰C/min, and finally plunged into liquid nitrogen (Saragusty 
& Arav, 2011). During this slow decrease in temperature, permeating cryoprotectants 
enter the cell as water exits, localizing the formation of ice crystals to the extracellular 
solution as the intracellular matrix reaches a temperature at which it forms a solid (Mazur, 
1963). Dehydration is not complete, however, and ice crystals can form within the cell, 
damaging organelles and causing cell death (Fahy, MacFarlane, Angell, & Meryman, 
1984; Gupta, Singh, & Anzar, 2016; Mazur, 1963). Cryopreservation is significantly less 
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successful in bovine embryos produced in vitro as compared to those produced in vivo 
(Enright et al., 2000).  
Vitrification was introduced as an alternative to slow freezing because it transforms 
the intracellular matrix into a non-crystalline amorphous solid, eliminating the event of 
intracellular crystallization (Fahy et al., 1984). This glass-like state is induced as a result 
of an extreme elevation in viscosity in the presence of a high concentration (40% w:v) of 
cryoprotectant (Fahy et al., 1984; Massip, 2001). After the embryo is dehydrated by culture 
with non-permeating cryoprotectants such as sucrose, the cytoplasm supercools until it 
vitrifies, thereby halting cellular processes while maintaining the ionic and molecular 
distribution of the liquid state (Massip, 2001; Mazur, 1963; Vajta & Kuwayama, 2006). As 
a result, mechanical and chemical damage to the cell is avoided (Massip, 2001). While 
vitrification yields a higher post-warm survival of embryos (Dobrinsky, 2002; Gupta et al., 
2016; Massip, 2001; Vajta & Kuwayama, 2006), there is evidence that exposure to high 
concentrations of cryoprotective agents causes irreplaceable damage to the cytoskeleton 
and mitochondria of the embryo and can cause osmotic shock in the cells (Dobrinsky, 
2002; Massip, 2001; Vajta & Kuwayama, 2006). 
Both slow freezing and vitrification techniques expose embryos to cryoprotectants 
and extreme temperature change, which are detrimental to embryo survival. There are 
two approaches to improving survival following cryopreservation: 1) modify the 
cryopreservation technique; or 2) modify the IVC technique to create a more resilient 
embryo (Dobrinsky, 2002; Seidel, 2006). Initial efforts focused on evolving the slow 
freezing technique. Determining the optimum cooling rate, cryoprotectant, thawing 
procedure, stage of embryo to freeze, and developing a direct transfer method allowed for 
moderate improvement in commercial application of this procedure (Massip, 2001). 
However, pregnancy rates of frozen embryos remains lower than optimum (Massip, 2001). 
Because the very qualities that decrease cryotolerance seem to be a result of 
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inefficiencies in culture conditions, research has been directed toward improving the IVC 
system.  
There are a number of structural and functional differences between in vivo-
derived and IVP embryos that contribute to the multi-functional event of cryosurvival (M. 
Sudano et al., 2013). In vivo-derived blastocysts are characterized by having a narrow 
perivitelline space, plasma membranes with a continuous cover of numerous stacked 
microvilli, a well-defined system of cell-to-cell coupling and a large population of round or 
elongated mitochondria with extensive transverse cristae (Fair et al., 2001); conversely, 
IVP blastocysts are characterized by a wider perivitelline space, no stacking of microvilli, 
decreased junctional contacts between trophoblast cells, and a notable increase in 
cytoplasmic lipid droplets (Fair et al., 2001). An accrual of intracellular lipids not only 
makes embryos more susceptible to oxidative damage (McEvoy, Robinson, & Sinclair, 
2001), but also impairs their ability to survive the phase changes that occur in the freeze-
thaw cycle (Seidel, 2006).  
It is not only the origin of embryos (in vivo vs. IVP) that determines their pregnancy 
rate after transfer, but also the act of slow freezing itself. One piece of evidence that points 
to invisible qualitative differences between fresh and frozen-thawed embryos is the 
difference in pregnancy rates following transfer of embryos of equal grade (Hasler, 2001). 
The transfer of grade 1 embryos of in vivo origin that have not been frozen (n=4163) 
resulted in a 73.2% pregnancy rate, as compared to a 62.8% pregnancy rate of grade 1 
embryos of in vivo origin that had been frozen and thawed (n=2482) (Hasler, 2001). 
Cryotolerance may be used as a tool for the ultimate measure of embryo quality 
(Dobrinsky, 2002; Seidel, 2006).  
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1.3 Energy metabolism  
As a fertilized oocyte develops, it proceeds through various stages of energy 
requirement. There are two mechanisms for ATP production in the pre-implantation 
embryo: oxidative phosphorylation and glycolysis (Jeremy G Thompson, Partridge, 
Houghton, Cox, & Leese, 1996). During the initiation and continuation of cleavage, bovine 
embryos rely on pyruvate as an energy substrate for oxidative phosphorylation as the 
glycolytic pathway is limited (H. J. Leese, 2012; Rieger, 1992). Other substrates that have 
been studied as sources of energy throughout development are amino acids, lactate, and 
endogenous fatty acid stores derived from triglyceride (H. J. Leese, 2012; R. G. Sturmey, 
Brison, & Leese, 2008). During genome activation, the glycolytic pathway begins to 
increase in function as glucose becomes the primary energy substrate, an occurrence 
which may be explained by the synthesis of one or more key glycolytic enzymes, such as 
hexokinase and phosphofructokinase, beginning at genome activation [Fig. 1] (Gardner, 
Pool, & Lane, 2000; Rieger, 1992). Genome activation occurs between the 8 and 12-cell 
stage in the bovine embryo (Telford, Watson, & Schultz, 1990).   
Energy requirements and oxygen uptake remain fairly constant from the 1-cell to 
8-cell stage; however, ATP production, oxygen consumption, glucose uptake, and oxygen 
uptake all increase at the morula stage (Jeremy G Thompson et al., 1996). The utilization 
of anaerobic respiration for ATP production is important between genome activation and 
blastocoel formation for several reasons. First, these stages coincide with the transition of 
the embryo from the oviduct to the uterus, which is hypothesized to reflect a drop in oxygen 
tension (Jeremy G Thompson et al., 1996). Oxygen tension of the reproductive tract of 
mammals ranges from 2-9%, with the uterus often exhibiting a lower tension than the 
oviduct (Fischer & Bavister, 1993). Second, the Na+/K+ ATPase pump has to begin 
working to form the blastocoel cavity, and protein synthesis also begins as the genome is 
activated, which both require the additional energy provided by glycolysis (Jeremy G 
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Thompson et al., 1996). It was determined that the embryo switches to a glycolytic 
pathway of metabolism because of the production of lactate as a by-product at this stage 
(Jeremy G Thompson et al., 1996).  
During in vitro culture, however, there seems to be a disproportionate increase in 
the glycolytic rate of metabolism that is linked to lower developmental competence of 
embryos (H. J. Leese, 2012). In a concept known as the ‘quiet embryo hypothesis,’ it is 
theorized that embryos which minimize oxygen consumption from the zygote to the morula 
stage may lessen the formation of oxygen radicals, limiting damage to cellular and 
molecular processes occurring during this time, such as cell division and gene expression 
(Henry J. Leese, 2002). The production of oxygen radicals as a side effect of oxidative 
phosphorylation inhibits development by causing membrane lipid peroxidation, enzyme 
inactivation, and DNA damage (Rieger, 1992). If an embryo is more ‘noisy,’ it signifies a 
need for greater amounts of energy and nutrients directed toward repair processes 
(Baumann, Morris, Sreenan, & Leese, 2007). As a result of this hypothesis, oxygen 
consumption may be a marker for developmental competence and the culture of embryos 
in a low (5%) oxygen environment rather than an atmospheric (20%) environment may 
promote continued development through the reduction of reactive oxygen species (H. J. 
Leese, 2012; Henry J. Leese, 2002; Rieger, 1992).  
The plasticity of pre-implantation embryo metabolism has the benefit of offering 
leniency when culturing IVP embryos in sub-optimal conditions, but the detriment of 
making assessment of vital culture components difficult (Absalón-Medina et al., 2014; 
Gardner et al., 2000). Furthermore, the utilization of any one nutrient by an embryo is 
dependent on concentrations and ratios of other nutrients present, as well as enzymatic 
up- or down-regulation in response to this environment (Gardner et al., 2000). 
Endogenous stores of energy within the embryo come in the form of glycogen and 
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triglycerides, however, viability seems to be primarily maintained by exogenous energy 
substrates (de Souza, Salles, & Rosa e Silva, 2015).  
There are controversial conclusions on the role and potential toxicity of glucose in 
culture media (Gardner et al., 2000). While glucose is required for nucleic acid production 
and NADPH synthesis through the pentose phosphate pathway (Absalón-Medina et al., 
2014; Gardner et al., 2000), there is also an accumulation of lactate that results from 
glycolytic activity [Fig. 1] (Gardner et al., 2000). This buildup of lactic acid reduces 
intracellular pH and can disturb the function of normal cellular processes such as enzyme 
activity, cell division, differentiation, and cytoskeletal dynamics (B. Bavister, 1999).  
The presence of glucose within culture media may initiate what is known as the 
crabtree effect, in which glucose inhibits mitochondrial respiration and promotes the less 
efficient utilization of glycolysis for ATP production (Seshagiri & Bavister, 1991). The 
cause of this effect is still relatively unknown, however. It may be that the mechanism for 
shuttling reducing equivalents across the outer mitochondrial membrane is impaired in in 
vitro cultured embryos, causing embryos to utilize the glucose present in their 
surroundings for lactate production to generate NAD+, a reducing equivalent (Jeremy G 
Thompson et al., 1996).  
Fructose has been suggested as an alternative energy source for embryos in 
culture due to its presence in the reproductive tract of the cow (Barceló-Fimbres & Seidel, 
2007a). Fructose results in higher blastocyst yield per oocyte and per 8-cell embryo than 
glucose, and does not have the putative toxic effects (Barceló-Fimbres & Seidel, 2007a). 
When glucose is phosphorylated in the first step of glycolysis, glucose-6-phosphate can 
fail to inhibit hexokinase activity in the embryo, causing continued phosphorylation of 
glucose [Fig. 1] (Gardner et al., 2000). The cell withdraws this phosphate from its 
mitochondrial supply, depleting mitochondrial pools of phosphate and subsequently 
decreasing ATP production within the mitochondria (Gardner et al., 2000). Because 
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fructose is a hexose that can serve as an energy substrate without requiring hexokinase, 
this may explain the reduction in negative effects seen from substituting some or all of the 
glucose with fructose.  
Studies such as this show that culture media has ample room for improvement as 
more is learned of embryo metabolism. In addition to the evolution of culture media 
through improvement of energy substrate provision, the addition of metabolic regulators 
may aid in regulation of glucose uptake in embryos post-compaction as well as combat 
some negative artifacts of IVC (Absalón-Medina et al., 2014; Barceló-Fimbres & Seidel, 
2007a).  
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Figure 1. Glucose metabolism within the cell. Glucose is broken down into pyruvate 
through a series of enzymatic reactions during glycolysis, generating ATP and NADH. 
Pyruvate is converted to acetyl Co-A where it can then enter the tricarboxylic acid (TCA) 
cycle to generate NADH and FADH2, which will go on to donate electrons for oxidative 
phosphorylation within the electron transport chain, ultimately producing ATP.  
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1.4 Intracellular lipids 
Lipids within the cytoplasm of the oocyte and embryo serve as an endogenous 
energy source for a variety of biological functions (R. Sturmey, Reis, Leese, & McEvoy, 
2009). Triglycerides within the ooplasm have an important role in energy provision during 
oocyte maturation, as seen by the sharp reduction in lipid content after this event (E M 
Ferguson & Leese, 1999). Because of this role, insufficient lipid content within the ooplasm 
as indicated by a pale coloration may signify a less viable oocyte due to the lack of 
necessary substrates for ATP production; this ATP is required for oocyte maturation 
(Jeong et al., 2009). Lipids are also essential for membrane biosynthesis, hormone 
synthesis, and cell signaling (Dunning, Russell, & Robker, 2014; Sutton-McDowall, Feil, 
Robker, Thompson, & Dunning, 2012). Cattle embryos have a particularly high lipid 
content when compared to human and mouse embryos, which is potentially due to the 
significant expansion that occurs prior to implantation, as compared to the limited 
expansion seen in the human embryo (Gardner et al., 2000; R. Sturmey et al., 2009). 
Additionally, in comparison to human and mouse embryos, cattle embryos remain 
unattached for a longer amount of time in the uterus, thus requiring a larger supply of 
endogenous energy prior to implantation (R. Sturmey et al., 2009).  
Triglycerides are stored within the cell in droplets surrounded by a phospholipid 
monolayer and lipid droplet coat proteins, which regulate droplet size and access of certain 
lipases (Dunning et al., 2014). The cells within an embryo utilize triglycerides as an energy 
source by first cleaving the fatty acids from their glycerol backbone through the action of 
three sequential lipase enzymes: adipose triglyceride lipase, hormone-sensitive lipase, 
and monoglyceride lipase (Dunning et al., 2014). These fatty acids are primarily palmitic 
(32%), oleic (25.1%), and stearic (14.2%), with saturated fatty acids being more abundant 
(49%) than mono-(38%) and poly-unsaturated (14%) acids (Mcevoy, Coull, Broadbent, 
Hutchinson, & Speake, 2000). Fatty acids are then converted to acyl-CoA by fatty acyl 
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CoA synthase and transported into the mitochondria through the binding of acyl-CoA to L-
carnitine by carnitine palmitoyl transferase 1B (CPT1B) on the outer mitochondrial 
membrane [Fig. 2] (Sutton-McDowall et al., 2012). Acyl-carnitine is translocated through 
the inner mitochondrial membrane by carnitine translocase (CAT), where it is then 
converted back to acyl-CoA by carnitine palmitoyl transferase 2 (CPTII) on the inner 
mitochondrial membrane (Sutton-McDowall et al., 2012). Acyl-CoA undergoes β-oxidation 
within the mitochondrial matrix to produce acetyl-CoA, while carnitine is shuttled back into 
the cytoplasm by CAT (Sutton-McDowall et al., 2012). This acetyl-CoA then enters the 
citric acid cycle and produces precursors for energy capture in the form of ATP (Sutton-
McDowall et al., 2012). The rate-limiting step in this process is the action of CPT1B, which 
is facilitated by the presence of L-carnitine (Sutton-McDowall et al., 2012). 
Further evidence for the use of intracellular lipids as an energy source is the 
rearrangement of mitochondria to be in close proximity to lipid droplets within the oocyte 
in response to the LH surge (Hyttel, Fair, Callesen, & Greve, 1997). This provides an easily 
accessible and potent energy supply to the mitochondria. Glucose metabolism yields 
between 27 and 31 moles of ATP, while oxidation of palmitate yields around 104 moles of 
ATP (R. Sturmey et al., 2009).  Finally, and perhaps most compellingly, oocytes are able 
to develop into blastocysts after in vitro fertilization or parthenogenesis when cultured in 
the complete absence of exogenous energy sources, however, they are not able to 
develop when triglyceride metabolism is inhibited under the same conditions (Elizabeth M 
Ferguson & Leese, 2006).  
It has been shown that impaired embryonic metabolism in an in vitro setting can 
cause abnormal lipid accumulation due to sub-optimal media composition (Barceló-
Fimbres & Seidel, 2007b). Altering embryonic metabolism may provide a way to reduce 
this lipid accumulation and improve development rates as the embryos are rescued from 
oxidative stress (Absalón-Medina et al., 2014; Paschoal et al., 2012). These elevated lipid 
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levels negatively influence cryotolerance; however, the exact mechanism by which this 
occurs is unknown (Abe, Yamashita, Satoh, & Hoshi, 2002; L. Baldoceda, Gagne, 
Ferreira, & Robert, 2015; Seidel, 2006). It is possible that lipids influence cryotolerance by 
lipid peroxidation (Barceló-Fimbres & Seidel, 2007b), or by changing the composition of 
cellular membranes by uptake from culture media and integration into existing membranes 
(Shehab-El-Deen, Leroy, Maes, & Van Soom, 2009). Lipid accumulation also increases 
cell volume and may lead to osmotic stress within the embryo (E M Ferguson & Leese, 
1999). Lastly, cryopreservation generates an increased level of oxygen radicals, which 
may be compounded by the additional oxygen radicals created from an elevated lipid 
content in IVP embryos, leading to cell death when the two factors are combined (Barceló-
Fimbres & Seidel, 2007b).  
There are multiple classes of lipids that affect embryo cryotolerance: 
triacylglycerides (TAG; cytoplasmic lipids), free fatty acids (FFA), cholesterol (membrane 
lipid), and phospholipids (membrane lipid) (M. Sudano et al., 2013). Of these, TAG seem 
to be the most influenced by IVC (Abe et al., 2002). TAG may increase in IVP embryos as 
a result of the Crabtree effect, in which there is a rise in the concentration of lipid synthesis 
precursors due to an excess of glycolysis and an inhibition of oxidative phosphorylation 
(Rieger, 1992; M. J. Sudano et al., 2011). Delipation experiments provide evidence for the 
interference of lipids with cryopreservation, as the removal of lipids through centrifugation 
increases tolerance to cryopreservation (Ushijima, Yamakawa, & Nagashima, 1999). 
Studies such as this suggest that delipation could be an effective technique for improving 
cryosurvival of bovine embryos (R. Sturmey et al., 2009). This concept has translated into 
the study of chemical delipation through the addition of metabolic regulators that promote 
lipolysis to embryo culture medium (M. Sudano et al., 2013).  
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Figure 2. Fatty acid transport into the mitochondria and metabolic pathway. Fatty 
acids are converted to Acyl-CoA, then bound to carnitine by carnitine palmitoyl transferase 
1B (CPT1B). Acyl-Carnitine + CoA is transported through the outer and inner 
mitochondrial membranes by carnitine translocase (CAT). Carnitine is removed and Acyl-
CoA is regenerated by carnitine palmitoyl transferase 2 (CPTII). Acyl-CoA then undergoes 
β-oxidation to generate Acetyl-CoA, which enters the tricarboxylic acid (TCA) cycle to 
generate electron donors for the electron transport chain.  
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1.5 Mitochondrial function  
Mitochondria are maternally inherited organelles responsible for ATP production 
through oxidative phosphorylation and originate from a defined founder population within 
the oocyte (Cummins, 2004; Dumollard, Duchen, & Carroll, 2007). The importance of 
oxidative phosphorylation as an energy source for maturing oocytes and developing 
embryos has given rise to the study of mitochondrial activity as an indicator of 
developmental competence (Tarazona, Rodríguez, Restrepo, & Olivera-Angel, 2006). 
Mitochondria may regulate development of the embryo through modulation of Calcium 
signaling, generation of ATP, maintenance of intracellular redox potential, and initiation of 
apoptosis (Dumollard et al., 2007). Mitochondria produce both reactive oxygen species 
(ROS) and reducing equivalents (NAD(P)H/NAD(P)+), a balance of which is crucial for 
proper development (Dumollard, Carroll, Duchen, Campbell, & Swann, 2009; Dumollard 
et al., 2007).  
The oocyte and early embryo up to the eight cell stage contain immature, ovoid-
shaped mitochondria with peripheral and underdeveloped cristae (Plante & King, 1994). 
It is controversial whether these immature mitochondria are efficient energy producers. 
While it would seem that the immature structure of the mitochondria would hinder energy 
derivation potential, mitochondrial activity increases during oocyte maturation for the 
continuation of events such as nuclear maturation, cytoplasmic maturation, cytoskeletal 
rearrangement, and mRNA accumulation (Tarazona et al., 2006).  Between the 8-cell and 
morula stage, mitochondria mature and become elongated with well-developed transverse 
cristae (Houghton & Leese, 2004; Plante & King, 1994). Although this maturation indicates 
a more competent mitochondrion, early embryonic divisions up to the 8 cell stage are 
marked by low to intermediate mitochondrial activity, and genome activation signifies a 
decrease to very low mitochondrial activity (Tarazona et al., 2006). This may be because 
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genome activation coincides with a switch to alternate energy derivation pathways, such 
as glycolysis (Jeremy G Thompson et al., 1996).  
Pre-implantation embryos are particularly sensitive to oxidative stress (Dumollard 
et al., 2009). If this oxidative stress does not lead to cellular apoptosis or developmental 
arrest, it may impair mitochondrial function by causing a redox imbalance and interfere 
with the embryo’s ability to properly utilize energy substrates, creating a buildup of 
intracellular lipids and inferior embryo quality (Gad et al., 2012). Mitochondrial dysfunction 
can also affect vital processes such as spindle organization, chromosomal segregation, 
timing of the cell cycle, compaction, cavitation, and blastocyst hatching (Van Blerkom, 
2004). These abnormalities highlight the important balance of antioxidants and ROS 
maintained by the mitochondria (Dumollard et al., 2009, 2007; Gad et al., 2012). Typically, 
bovine embryos in an in vitro setting accumulate an excess of ROS that exceed the 
antioxidant capacity that the embryo naturally generates through metabolic intermediates 
and reducing equivalents from the TCA cycle (Dumollard et al., 2009). As a result, much 
effort has been focused on optimizing the redox state of the embryo. This was initially 
done by reducing the oxygen tension of the culture environment from 20% to 5% O2, 
however, these conditions do not completely remedy the increased ROS (Rieger, 1992). 
The addition of antioxidants to culture medium has since become a prominent approach 
to address this issue (Fakruzzaman et al., 2015).  
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1.6 Metabolic regulators  
 When considering an alteration to embryo culture medium, there are multiple 
factors that must be taken into account. The addition of an exogenous chemical to culture 
medium may have detrimental downstream effects depending on the stage of 
development that the embryo is in and the pathway of action of the substance. It is 
important to consider whether the chemical or molecule will interfere with major life events 
of the embryo, such as genome activation, mitochondrial maturation, and/or compaction 
(Gad et al., 2012). 
1.6.1 L-Carnitine 
L-carnitine facilitates the rate-limiting step of fatty acid transport into the 
mitochondria [Fig. 2] (Sutton-McDowall et al., 2012). For this reason, this substance has 
been looked to as a potential regulator of fatty acid metabolism (M. Sudano et al., 2013). 
Addition of L-carnitine to IVC medium has been shown to decrease intracellular lipid 
accumulation, improve blastocyst development rate, and decrease ROS in bovine 
embryos (L. Baldoceda et al., 2015; T. Takahashi et al., 2013). This is a peculiar 
occurrence because the up-regulation of fatty acid metabolism and increased metabolic 
rate would imply an increase in ROS (Takahashi et al., 2013). However, L-carnitine seems 
to serve as an antioxidant by scavenging free radicals, resulting in a net decrease of ROS 
within the embryo (Baldoceda et al., 2015; Takahashi et al., 2013).  Consequently, 
because of the correlation between intracellular lipid content and cryotolerance (Abe et 
al., 2002), the reduction of lipids by L-carnitine offers a non-invasive way to improve 
freezing survival of bovine embryos (L. Baldoceda et al., 2015; T. Takahashi et al., 2013).  
1.6.2 Forskolin 
 Forskolin is a diterpene molecule that was discovered to activate adenylate 
cyclase on the membranes of cells (Seamon, Padgett, & Daly, 1981). Forskolin is unique 
in that it acts in a reversible manner on the cAMP-generating systems within a cell 
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(Seamon et al., 1981). An increased level of intracellular cAMP initiates a release of the 
catalytic subunits of protein kinase A (PKA) from the regulatory subunits, which in turn 
activate endogenous lipase enzymes, such as hormone sensitive lipase, through 
phosphorylation [Fig. 3] (Londos et al., 1999; Men, Agca, Riley, & Critser, 2006). These 
lipase enzymes go on to hydrolyze TAG into fatty acids and glycerol, freeing the fatty acids 
to undergo β-oxidation (Men et al., 2006). Forskolin was first studied as a culture medium 
additive in porcine embryos and found to significantly reduce cytoplasmic lipids (Men et 
al., 2006). Subsequent experiments in bovine IVC have shown that addition of forskolin to 
culture medium improves cryosurvival without negative effects on embryo development 
(Paschoal et al., 2012; Sanches et al., 2013).  
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Figure 3. Lipolytic pathway of forskolin within the cell. Forskolin activates adenylate 
cyclase on the membranes of cells, which increases intracellular cyclic adenosine 
monophosphate (cAMP). cAMP then binds to the catalytic subunits of phosphokinase A 
(PKA), which goes on to activate the lipase enzymes involved in breaking down 
triacylglycerol into free fatty acids that can be metabolized for ATP synthesis. 
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1.6.3 Vitamin K2 
It was recently found that vitamin K2 is able to restore mitochondrial function in a 
strain of Drosophilia engineered with a genetic mutation affecting their mitochondria (Vos 
et al., 2012). From this study it was concluded that vitamin K2 serves as an electron carrier 
in eukaryotic cells and affects mitochondrial remodeling through the restoration of efficient 
ATP production [Fig. 4] (Vos et al., 2012). Ovoid and immature mitochondria signify a 
deficiency in energy utilization (Vos et al., 2012) and developmental incompetence (Van 
Blerkom, 2009). This trend is often observed in IVP bovine embryos, indicating there is 
mitochondrial dysfunction in these cells as a result of culture conditions (Abe et al., 2002). 
It was initially believed that mitochondrial dysfunction was a result of oxidative stress from 
the production of free radicals, but the failure of antioxidant culture additives to restore 
mitochondrial function may signify an ineptitude of mitochondria in IVP embryos 
(Baldoceda-Baldeon, Gagne, Vigneault, Blondin, & Robert, 2014). A recent study has 
shown that vitamin K2 as a culture media additive improves bovine embryo phenotype, 
and has the potential to increase blastocyst development rates by rescuing embryos that 
would have otherwise ceased development (Baldoceda-Baldeon et al., 2014). 
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Figure 4. Proposed mechanism of vitamin K2 within the electron transport chain. 
Vitamin K2 receives electrons from complexes I and II and transports the electrons to 
complex III. This prevents premature loss of electrons from the transport chain and 
reduces the generation of reactive oxygen species by the conversion of oxygen to water.  
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1.6.4 Coenzyme Q10  
 Similar to vitamin K2, it is theorized that supplementation of coenzyme Q10 to 
embryo culture medium may improve development rates by restoring disturbed function 
of the electron transport chain (Stojkovic et al., 1999). Coenzyme Q10 is an electron carrier 
that resides in the intermembrane space of the inner mitochondrial membrane bilayer, 
transporting electrons from complexes I and II to complex III [Fig. 4] (Stojkovic et al., 1999). 
Vitamin K2 and coenzyme Q10 are both lipophilic and insoluble, making the addition of 
these molecules to water-based culture medium a challenge. Coenzyme Q10 is made 
soluble through a method of creating a submicron-sized dispersion within a stabilizing 
solvent (Stojkovic et al., 1999). It has been shown that the addition of this solution to 
culture medium has positive effects on blastocyst formation, cell proliferation, hatching, 
and ATP content of bovine embryos, possibly due to a restoration of proper electron 
transport chain function (Stojkovic et al., 1999). 
1.6.5 Conditioned media 
 The prolonged exposure of IVC embryos to imperfect culture conditions has given 
rise to developmental abnormalities and a blastocyst rate that remains relatively low (Chen 
et al., 1994). A proposed remedy for the shortcomings of embryo culture medium is a co-
culture system in which a population of feeder cells supplies specific growth factors to the 
medium in which the embryos develop (Chen et al., 1994). This technique originates from 
the theory that embryos cultured in vitro lack the cell to cell interaction that is present in 
vivo, thereby lacking exposure to specific hormones, growth factors, and cell signaling 
factors that the niche environment provides (Maeda, Kotsuji, Negami, Kamitani, & 
Tominaga, 1996). Modifications of this co-culture system now include extracting the media 
used to nourish a cell monolayer and re-distributing it to the media of another culture 
system (Chen et al., 1994).  
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 Vero cells, derived from kidney cells of the Green African monkey, have been used 
as a source for co-culture serum extraction because they are inexpensive, easy to handle, 
and pathogen-free as a result of their use in vaccine-production (Chen et al., 1994). 
Specifically, these cells produce interleukin, platelet-derived growth factor, Leukemia 
inhibitory factor, and insulin-like growth factor, which are considered embryotrophic 
because of their stimulatory effect on embryonic development (Tavares et al., 2011). In 
studies performed with mouse embryos, co-culture with Vero cells themselves as well as 
with peptides extracted from the cellular monolayer resulted in rescue from the 
developmental block usually encountered before the blastocyst stage (Chen et al., 1994). 
Later studies with bovine embryos showed that the proteins, cell signaling molecules, and 
growth factors found in this cellular monolayer serum had similar embryotrophic effects 
(Maeda et al., 1996).  
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1.7 Summary 
 To date, many deficiencies still reside in the process for commercial production of 
embryos in vitro. Research into the mechanisms of developmental control of bovine 
embryos has allowed for moderate improvements in development rates, but progress is 
still needed. What is known is that dysfunction in energy metabolism results in abnormal 
accumulation of intracellular lipids, causing decreased cryotolerance (Barceló-Fimbres & 
Seidel, 2007b). The mostly likely sources of this dysfunction are inadequacies in culture 
media (Barceló-Fimbres & Seidel, 2007b). Research focusing on the rescue of embryos 
from the detrimental effects of an in vitro environment through enhancement of culture 
media composition is a promising approach toward improving the quality, cryotolerance, 
and overall competence of bovine IVP embryos. 
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Chapter 2. Common Materials and Methods  
2.1 Materials  
All materials used for in vitro embryo production were obtained from MOFA Global, 
LLC, Verona, WI, USA and all chemicals were obtained from Sigma-Aldrich, St. Louis, 
MO, USA unless otherwise stated.  
2.2 In vitro embryo production  
Embryos for each experiment and pilot study were produced by the following 
methods with modifications as described in respective chapters.  
2.2.1 Oocyte collection 
Ovaries were acquired from a local abattoir and transported to the laboratory at 
ambient temperature (22⁰C - 25⁰C) in 0.9% NaCl saline solution (Abbott Laboratories, 
Abbott Park, IL, USA) within 3 h of slaughter. Oocytes were aspirated from 2 to 8 mm 
follicles using an 18-ga needle attached to a vacuum pump with 25 to 30 mm Hg of 
pressure.  Oocytes were held in OPU medium containing 0.3% BSA and 50 μg/mL heparin 
(19982/1281; MOFA Global) during aspiration then washed three times in oocyte wash 
medium containing 0.3% BSA (19982/1200; MOFA Global) and 2.5 μg/mL gentamicin 
(Sigma-Aldrich). Immature oocytes containing at least three layers of compact cumulus 
cells were selected for IVM.  
2.2.2 In vitro maturation  
Cumulus-oocyte-complexes (COCs) were matured in CO2-gassed bicarbonate-
based medium designed for using a conventional maturation system. Groups of 
approximately 40 COCs were placed into 0.8 mL tissue culture medium (TCM) -199 
supplemented with 10% fetal calf serum (v:v; Thermo Fisher Scientific, Waltham, MA, 
USA), 0.4 mM pyruvate, 5 IU bovine FSH and LH, and 0.625 μg/mL gentamicin (Sigma-
Aldrich).  COCs were incubated at 38.5⁰C in 5% CO2 humidified air for 23 h.  
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2.2.3 In vitro fertilization 
Expanded COCs were transferred in groups of 50 to 0.45 mL pre-equilibrated 
fertilization chemically defined fertilization medium (FCDM) containing 0.5% BSA, 2.0 
μg/mL heparin (H-3125; Sigma) and 5 mM caffeine (9982/1266; MOFA Global). Semen 
from  bulls (n=2 to 3) with proven fertility was processed through a 45 and 90% Percoll 
gradient and centrifuged at 400 x g at 23⁰C for 12 min. The pellet was removed and 
washed in 1 mL FCDM, then centrifuged again at 400 x g at 23⁰C for 4 minutes. The 
supernatant from the final wash was removed and the concentration of sperm cells in the 
resulting pellet was measured using a hemocytometer (Bright-Line; Hausser Scientific, 
Horsham, PA, USA) and inverted microscope (Olympus IX71; Center Valley, PA, USA). 
The pellet was diluted to a final concentration of 5 x 105 sperm/mL using FCDM. Co-
incubation in a final volume of 0.5 mL took place at 38.5⁰C in 5% CO2 humidified air for 20 
h.  
2.2.4 Embryo culture 
Presumptive zygotes were removed from culture dishes in groups of 150 and 
placed into a 0.5 mL Eppendorf tube with 50 uL oocyte washing medium. Tubes were 
vortexed at maximum speed for 2 min to remove cumulus cells and presumptive zygotes 
were washed through drops of oocyte medium. Presumptive zygotes were placed into pre-
equilibrated defined embryo culture media (BBH7 (MOFA Global or SOF based media 
(SCF1, SOF for Conventional Freezing 1)) drops at a ratio of 1.5 to 2.0 uL media per 
zygote, covered with mineral oil (Sigma-Aldrich), and cultured at 38.5⁰C in 5% CO2, 5% 
O2 and 90% N2 (v:v) for 7 to 9 days. 
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2.3 Evaluation of embryos   
 The following evaluative methods were used to assess embryos in each pilot study 
and experiment with modifications as described in respective chapters.  
2.3.1 Cleavage and development  
Cleavage and 5 to 8 cell development were assessed using a stereomicroscope 
2.5 days after fertilization. Blastocyst rate was evaluated at 7, 8, and 9 days after 
fertilization and calculated as a percentage of total oocytes placed into culture. Stage (5: 
early blastocyst, 6: blastocyst, 7: expanded blastocyst, 8: hatched blastocyst) and grade 
(1: excellent, 2: fair, 3: poor, 4: dead) of blastocysts were recorded at days 7 and 8 
according to the guidelines of the International Embryo Transfer Society (Robertson & 
Nelson, 1998).  
2.3.2 Lipid content  
To quantify lipid accumulation, stage 7 blastocysts of grades 1 or 2 were fixed in 
10% paraformaldehyde (v:v) for at least 24 h. A 1 mg/mL stock solution of Nile Red dye 
(Sigma-Aldrich) was prepared in DMSO and stored at room temperature in the dark. Fixed 
embryos were washed in three drops of PBS-PVP then stained in a 1 μg/mL solution of 
Nile Red dye in PBS-PVP for 30 min. Embryos were washed again with PBS-PVP and 
mounted in a 1:10 (v:v) dilution of ProLong Diamond Antifade Mountant (ThermoFisher 
Scientific, Waltham, MA, USA) in PBS. Images were acquired at an excitation/emission 
wavelength of 488/520 (imaging technique described in respective chapters). As a 
negative control, embryos were placed in 99% ethanol for 18 h after fixation to dissolve 
intracellular lipids then stained and imaged as previously described.  
2.3.3 Mitochondrial polarity  
Mitochondrial polarity was assessed by staining stage 7 blastocysts of grades 1 or 
2 with an active mitochondrial dye that binds differentially based on mitochondrial 
membrane potential. Live embryos were cultured in SCF1 medium containing 300 nM 
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MitoTracker Red CMX-rosamine (Molecular Probes, Eugene, OR, USA) for 45 min at 
38.5⁰C in 5% CO2 humidified air. As a negative control, a group of live embryos were 
randomly selected to be cultured in 100 nM carbonyl cyanide m-chlorophenylhydrazone 
(CCCP), a mitochondrial membrane uncoupler, in addition to MitoTracker Red CMX-
rosamine. Embryos were washed in three drops of PBS-PVP and fixed in 10% 
paraformaldehyde (v:v) for 24 h. Embryos were then stained with 1 μg/mL DAPI for 10 
min, washed with PBS-PVP, and mounted in a 1:10 (v:v) dilution of ProLong Diamond 
Antifade Mountant (ThermoFisher Scientific, Waltham, MA, USA) in PBS for imaging. 
Imaging technique is explained in respective chapters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30 
 
Chapter 3. Pilot Study 1: Coenzyme Q10 Titration   
3.1 Introduction  
Coenzyme Q10 (CoQ) is a lipophilic antioxidant that is synthesized endogenously 
and found in the membranes of cells. There are three main functional roles of CoQ. First, 
in its fully oxidized ubiquinone form, it serves as an electron transporter from complexes I 
and II to complex III in the mitochondrial electron transport chain (Bentinger, Tekle, & 
Dallner, 2010). Second, in its fully reduced ubiquinol form, CoQ acts as an antioxidant in 
the inner mitochondrial membrane and inhibits lipid peroxidation by scavenging free 
radicals (Kwong et al., 2002). Third, in its partially reduced ubisemiquinone form, CoQ 
serves as a source of superoxide and hydrogen peroxide generation (Boveris, Cadenas, 
& Stoppani, 1976; Turrens, 1997). Thus, CoQ can act as both a pro-oxidant and an 
antioxidant, but its primary role is as an antioxidant (Kwong et al., 2002).  
It is believed that the increased oxidative stress in IVP embryos is a result of 
mitochondrial dysfunction, which causes a decrease in developmental competence (Gad 
et al., 2012). Impaired mitochondrial function also impedes development by causing a 
buildup of intracellular lipids due to improper utilization of energy substrates (Gad et al., 
2012). Particularly in an in vitro setting, bovine embryos seem to accumulate ROS that 
exceed their natural antioxidant capacity (Dumollard et al., 2009). Because of these 
negative effects of in vitro culture, research has focused on regaining a balance in redox 
state as a way to improve the quality of bovine IVP embryos, as measured by the 
percentage of oocytes that reach the blastocyst stage. 
While some studies have focused on the use of antioxidants to counter the 
accumulation of ROS (Fakruzzaman et al., 2015), there is an alternate approach to 
addressing this mitochondrial dysfunction. The addition of exogenous CoQ has shown 
promising benefit to IVP bovine embryo development (Stojkovic et al., 1999). When 
comparing several concentrations of CoQ (10 μM, 30 μM, and 100 μM) in a solubilized 
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submicron-sized dispersion, Stojkovic and associates have shown that a concentration of 
30 μM increased the percentage of blastocysts at 186 hours post insemination (hpi) and 
the percentage of hatched blastocysts 210 hpi when compared to the other concentrations 
and a control (Stojkovic et al., 1999). Additionally, in this study, the supplementation of 
culture media with 30 μM CoQ increased the total cell number of resulting blastocysts 
when compared to a negative control (Stojkovic et al., 1999).  
The objective of the present pilot study was to compare the effects of 10, 30, 100, 
and 300 μM CoQ within the given culture system. The concentration found to be most 
effective in improving embryo quality can then be used for subsequent experiments to 
determine the efficacy of CoQ in comparison to other metabolic regulators. Based on 
previous studies (Stojkovic et al., 1999), it was hypothesized that embryos cultured with 
30 μM CoQ would show an increase in blastocyst rate, a decrease in lipid content, and an 
increase in polarity of the inner mitochondrial membrane.  
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3.2 Materials and methods  
3.2.1 In vitro embryo production  
 Embryos were produced from oocytes (n=1252) as described in Chapter 2.2 with 
the following modifications.  
3.2.1.1 Addition of coenzyme Q10 
A 0.115 M stock of CoQ (Homogenous liposomal ubiquinol, Tishcon Corp, 
Westbury, NY, USA) was diluted to a 1.5 mM intermediate solution using chemically 
defined culture medium. At day 3 after fertilization, culture drops containing 20-25 fertilized 
oocytes were randomly assigned to receive one of five CoQ concentrations: 0 μM, 10 μM, 
30 μM, 100 μM, or 300 μM. Embryos were then allowed to culture in their respective 
treatments until day 8.  
3.2.2 Evaluation of embryos  
 Cleavage and development, lipid content, and mitochondrial polarity of embryos 
was evaluated as described in Chapter 2.3 with the following specifications.  
3.2.2.1 Embryo development  
 Percentage of oocytes that cleaved and reached the 5-8 cell stage was recorded 
but not used for analysis in this study due to treatment beginning at day 3. Percentage of 
oocytes reaching the blastocyst stage was recorded and analyzed for each treatment 
group.  
3.2.2.2 Lipid content 
 Lipid accumulation was quantified by staining stage 7 blastocysts with the lipophilic 
Nile Red dye as described in Chapter 2.3.2. Images were acquired by confocal microscopy 
at 40X magnification using an excitation/emission wavelength of 488/520 (Olympus 
Fluoview, Tokyo, Japan). Ten orthogonal projections along the equatorial section of the 
embryo were collected with a 5 μm step size. Fluorescence was measured using ImageJ 
software (National Institutes of Health, Bethesda, MD, USA) with background fluorescence 
33 
 
corrected for, and mean fluorescence between treatment groups was analyzed. Results 
are expressed in mean fluorescence arbitrary units (AUs). 
3.2.2.3 Mitochondrial polarity  
 Mitochondrial polarity was assessed using MitoTracker Red CMX-rosamine dye, 
which binds with varying affinity based on degree of mitochondrial polarity, as described 
in Chapter 2.3.3. Images were acquired by confocal microscopy at 40X magnification 
using an excitation/emission wavelength of 594/608 (Olympus Fluoview, Tokyo, Japan). 
Ten orthogonal projections along the equatorial section of the embryo were collected with 
a 5 μm step size. Fluorescence intensity was measured using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA) with background fluorescence corrected for, and 
mean fluorescence between treatment groups was analyzed. Results are expressed in 
mean fluorescence intensity arbitrary units (AUs). 
3.2.3 Experimental design  
 This experiment was designed as a titration of varying concentrations of CoQ: 0 
μM (control), 10 μM, 30 μM, 100 μM, and 300 μM. Embryos were randomly assigned to 
one of five treatment groups at 72 hpi. Blastocyst rate, lipid content, and mitochondrial 
polarity were recorded for each treatment group during each trial replicate (n=5).  
3.2.4 Statistical analysis  
 Blastocyst rate, lipid content, and mitochondrial polarity were evaluated by one 
way-ANOVA using the SAS statistical software package general linear model (GLM; SAS 
Institute, Cary, NC, USA). If the ANOVA was significant (P<0.05), means were separated 
by Tukey’s HSD. 
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3.3 Results 
3.3.1 Blastocyst rate 
 The blastocyst rate per oocyte was no different (P>0.05) among the control group 
and each concentration of CoQ (11.3% Control vs. 8.9% in 10 μM CoQ, 10.5% in 30 μM 
CoQ, 10.6% in 100 μM CoQ, and 7.0% in 300 μM CoQ) [Fig. 5]. 
3.3.2 Lipid content 
 Supplementing embryo culture media with 10 μM and 30 μM resulted in a decrease 
(P<0.05) in lipid content as compared to the control group (222.3 AFUs and 248.7 AFUs 
vs. 330.1 AFUs, respectively). No difference (P>0.05) was seen between the 100 μM or 
300 μM treatment group and the control (262.2 AFUs and 350.2 AFUs vs. 330.1 AFUs, 
respectively) [Fig. 6].  
3.3.3 Mitochondrial polarity 
 No difference (P>0.05) was seen between embryos cultured in the presence of 30 
μM CoQ and the control group (7904.3 AFUs vs. 8001.2 AFUs, respectively). However, 
embryos cultured in the presence of 10 μM, 100 μM, and 300 μM CoQ each had a 
decrease (P<0.05) in mitochondrial polarity as compared to the control (6788.0 AFUS, 
5713.7 AFUs, and 2112.8 AFUs vs. 8001.2 AFUs, respectively). Furthermore, the 10 μM, 
100 μM, and 300 μM treatments groups all differed (P<0.05) from one another, with 
mitochondrial polarity decreasing as the concentration of CoQ increased [Fig. 7].  
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Figure 5. Blastocyst rate between CoQ concentrations. Blastocyst development rates 
between treatment groups did not differ (P>0.05). Error bars represent standard error of 
the mean. N=5 replicates. 
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Figure 6. Lipid content between CoQ concentrations. Means of lipid content between 
treatment groups as represented by Nile Red AFUs (Control (n=50), 10 μM CoQ (n=78), 
30 μM CoQ (n=40), 100 μM CoQ (n=20), and 300 μM CoQ (n=40)). Error bars represent 
standard error of the mean, and values without common labels differ (P<0.05). 
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Figure 7. Mitochondrial polarity between CoQ concentrations. Means of mitochondrial 
polarity between treatment groups as represented by MitoTracker Red AFUs (Control 
(n=57), 10 μM CoQ (n=99), 30 μM CoQ (n=89), 100 μM CoQ (n=116), and 300 μM CoQ 
(n=68)). Error bars represent standard error of the mean, and values without common 
labels differ (P<0.05). 
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3.4 Discussion  
In this study, both 10 μM and 30 μM CoQ decreased lipid content of embryos. The 
overall benefit of this media additive was found to be limited, however, as there was no 
concurrent increase in blastocyst percentage or mitochondrial polarity with these 
treatments, which are believed to be markers for an increase in embryo viability. Previous 
studies have demonstrated that CoQ increases the proportion of oocytes that reach the 
blastocyst stage in a concentration-dependent manner, with 10 μM and 30 μM CoQ being 
the most effective concentrations, and 100 μM CoQ showing a decrease in blastocyst 
percentage (Stojkovic et al., 1999). It is believed that CoQ contributes to cell proliferation 
and growth by promoting ATP production within the inner mitochondrial membrane and 
balancing the redox state of cells (Schneider, Lemasters, & Hackenbrock, 1982; Sun, Sun, 
& Crane, 1992).  
The present study did not validate the proliferative effects seen by other 
researchers. Coenzyme Q10 is extremely lipophilic and resides in the intermembrane 
space of the inner mitochondrial membrane, making the delivery of this substance to its 
location of action a challenge. A previous study prepared a submicron-sized dispersion of 
CoQ for culture with bovine embryos to increase its bioavailability (Stojkovic et al., 1999). 
Other studies examining the effects of CoQ on cell lines have used liposomal CoQ as a 
delivery method (Schneider et al., 1982), which was the method used in the present study. 
Because liposomes pass through cellular membranes and deliver CoQ by fusing with the 
existing phospholipid bilayer, the length of the inner mitochondrial membrane increases 
as a result. This increase in length may also increase the distance between integral 
proteins involved in electron transport, thereby slowing the rate of metabolism occurring 
in the cell, which may explain the decrease in mitochondrial polarity seen as the 
concentration of liposomal CoQ increased (Schneider et al., 1982). Overall, the delivery 
of CoQ by liposomes was not shown to be an operative method of producing the positive 
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effects of CoQ on embryo development, although a concentration of 30 μM was the most 
effective relative to other concentrations examined. As a result of this pilot study, it was 
concluded that other metabolic regulators should be examined for their effectiveness in 
decreasing lipid content and increasing mitochondrial polarity, both individually and 
combined in comparison to CoQ. Additional factors affecting the evaluation of effects seen 
from culture with or without metabolic regulators should also be examined, such as stage 
of development at the time of evaluation and media type used for culture.  
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Chapter 4. Pilot Study 2: Media Type, Additive, Stage 
4.1 Introduction 
The conditions of post-fertilization embryo culture are the most significant factors 
affecting blastocyst quality (Rizos, 2002). Sequential culture media was developed to 
accommodate the embryo’s preference for oxidative phosphorylation during the 1-8 cell 
stage by providing pyruvate as an energy source (J. G. Thompson, 2000). Embryos are 
then transferred to a medium which provides a higher concentration of glucose so that 
glycolysis can occur during compaction and blastulation (J. G. Thompson, 2000). The 
culture of embryos in either sequential or continuous media may have an effect on the 
overall yield of blastocysts per oocyte, and may also affect the action of metabolic 
regulators added to the media.  
At the beginning of the blastocyst stage, activation of Na+/K+ pumps is necessary 
for the import of water to form the blastocoel cavity. Additionally, macromolecule synthesis 
increases as cell lineages are formed (Houghton & Leese, 2004). These energy-
demanding processes coincide with a switch to glucose as a substrate for ATP production. 
Lipid content decreases at this stage as free fatty acids are used as an energy source 
(Jeong et al., 2009). Lipid content then continues to decrease as the embryo expands 
(Jeong et al., 2009). Because of this stage-dependent change in triglyceride accumulation, 
it is important to know if alterations to the culture conditions show the same effects on both 
early (stage 6) and late (stage 7) stage blastocysts.  
In vitro-produced Holstein embryos accumulate an excess of intracellular lipids, 
which negatively impacts their ability to withstand cryopreservation (Abe et al., 2002; 
Barceló-Fimbres & Seidel, 2007a, 2007b; Enright et al., 2000; E M Ferguson & Leese, 
1999; Jeong et al., 2009). Chemical delipation through the addition of L-carnitine or 
forskolin is an approach for improving the quality and cryotolerance of bovine IVP embryos 
(Sanches et al., 2013; T. Takahashi et al., 2013). L-carnitine facilitates the transfer of free 
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fatty acids into the mitochondria for subsequent β-oxidation and metabolism (Sutton-
McDowall et al., 2012). Forskolin promotes lipolysis through an increase in intracellular 
cAMP, which activates key lipase enzymes that break triglycerides into free fatty acids 
(Dunning et al., 2014; Men et al., 2006). 
ATP production regulates the embryo’s progression through its first cellular 
divisions, activation of its native genome, and compaction of the morula, which involves 
establishing cell-to-cell contacts and differentiation of cell types into the trophectoderm 
and inner cell mass (Baldoceda-Baldeon et al., 2014; Dumollard et al., 2009; Gardner et 
al., 2000; Rieger, 1992; Rizos, 2002; Sutton-McDowall et al., 2012; Van Blerkom, 2004). 
Mitochondrial dysfunction may contribute to an accumulation of intracellular lipids as a 
result of lowered mitochondrial activity (Luis Baldoceda et al., 2016). Vitamin K2 is believed 
to work through a similar mechanism as coenzyme Q10, restoring proper function of the 
electron transport chain by serving as an electron carrier (Vos et al., 2012). By repairing 
dysfunctional mitochondria, CoQ and/or VitK may allow for mitochondria to continue the 
metabolism of free fatty acids when they would have otherwise halted, decreasing the 
accumulation of triglycerides within the cell. 
Chemically defined medium provides a way of studying the individual effects of 
specific growth factors or metabolic regulators on embryo development and ATP 
production (Lim et al., 2007). The objectives of this study were: 1) to determine if culturing 
embryos in a continuous versus sequential media has an effect on blastocyst yield or lipid 
accumulation, 2) to determine if the stage of development at which embryos are assessed 
affects the results of the study, and 3) to compare the effects of various metabolic 
regulators as additives to embryo culture. This study was separated into two parts to 
address these objectives. It was hypothesized that sequential media would increase 
blastocyst yield and decrease lipid accumulation, that stage of development at 
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assessment would not affect results observed, and that each additive would cause a 
decrease in lipid content and an increase mitochondrial polarity.  
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4.2 Materials and methods 
4.2.1 In vitro embryo production 
 Embryos were produced from oocytes (n=5070, part 1; n=3100, part 2) as 
described in Chapter 2.2 with the following modifications.  
4.2.1.1 Addition of L-carnitine 
 A 50 mM stock of L-carnitine (C0283; Sigma) was prepared and stored at -80⁰C 
until the day of use. After fertilization, presumptive zygotes were randomly assigned to 
culture medium that contained either 0 mM L-carnitine or 0.5 mM L-carnitine and cultured 
for 7 to 9 days. 
4.2.1.2 Addition of coenzyme Q10 
A 0.115 M stock of CoQ (Homogenous liposomal ubiquinol, Tishcon Corp, 
Westbury, NY, USA) was diluted to a 1.5 mM intermediate solution using embryo culture 
medium. At day 3 after fertilization, CoQ was added to randomly assigned culture drops 
containing 20-25 fertilized oocytes at a final concentration of 30 μM.  
4.2.1.3 Addition of vitamin K2 
 A 200 mM stock was prepared by dissolving vitamin K2 powder (V9378; Sigma) 
into 95.5% ethanol and freezing at -80⁰C. Vitamin K2 was added to randomly assigned 
embryo culture groups at day 3 after fertilization at a final concentration of 0.5 mM.  
4.2.1.4 Addition of forskolin 
 A 10 mM stock of forskolin was prepared by dissolving forskolin (344270; Sigma) 
into dimethyl sulfoxide solution and storing at -80⁰C. Forskolin was added to randomly 
assigned embryo culture groups at a final concentration of 10 μM on day 5 after 
fertilization.  
4.2.2 Evaluation of embryos  
 Lipid content and mitochondrial polarity of embryos was evaluated as described in 
Chapter 2.3.2-2.3.3 with the following specifications.  
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4.2.2.1 Lipid content 
 Lipid accumulation was quantified by staining blastocysts with the lipophilic Nile 
Red dye as described in Chapter 2.3.2. For part 1, images were acquired along the 
equatorial plane of the embryo at 40X magnification using a widefield fluorescent 
microscope equipped with a FITC filter (Zeiss Axioskop 40, Oberkochen, Germany). For 
part 2, images were acquired by confocal microscopy at 40X magnification using an 
excitation/emission wavelength of 488/520 (Olympus Fluoview, Tokyo, Japan). Ten 
orthogonal projections along the equatorial section of the embryo were collected with a 5 
μm step size.  
For both parts, fluorescence was measured using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA) with background fluorescence corrected for, and 
mean fluorescence between treatment groups was analyzed. Results are expressed in 
mean fluorescence arbitrary units (AFUs). 
4.2.2.2 Mitochondrial polarity  
 Mitochondrial polarity was assessed using MitoTracker Red CMX-rosamine dye, 
which binds with varying affinity based on degree of mitochondrial polarity, as described 
in Chapter 2.3.3. Images were acquired by confocal microscopy at 40X magnification 
using an excitation/emission wavelength of 594/608 (Olympus Fluoview, Tokyo, Japan). 
Ten orthogonal projections along the equatorial section of the embryo were collected with 
a 5 μm step size. Fluorescence intensity was measured using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA) with background fluorescence corrected for, and 
mean fluorescence between treatment groups was analyzed. Results are expressed in 
mean fluorescence intensity arbitrary units (AFUs). 
4.2.3 Experimental design  
 This experiment was designed in two parts. For part 1, a 2 x 2 x 2 factorial design 
was used to compare culture systems (continuous vs. 3-step sequential), blastocyst stage 
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(stage 6 (early) vs. stage 7 (late)), and cumulative additives (no additives vs. L-carnitine 
(0.5 mM at day 1), plus coenzyme Q10 (30 μM at day 3), plus vitamin K2 (0.5 mM at day 
3), plus forskolin (10 μM at day 5)). Total lipid content was used to evaluate embryos from 
each treatment group.  
 For part 2, a 2 x 2 X 2 X 2 factorial design was used to compare each additive 
(none vs. 0.5 mM L-carnitine at day 1, none vs. 30 μM CoQ at day 3, none vs. 0.5 mM 
VitK at day 3, and none vs. 10 μM forskolin at day 5) as well as all combinations of these 
additives. Mitochondrial polarity was used to evaluate late stage (stage 7) blastocysts from 
each treatment group.  
4.2.4 Statistical analysis  
 Lipid content and mitochondrial polarity were evaluated by one way-ANOVA using 
the SAS statistical software package general linear model (GLM; SAS Institute, Cary, NC, 
USA). If the ANOVA was significant (P<0.05), means were separated by Tukey’s HSD. 
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4.3 Results 
4.3.1 Media type (Part 1) 
 No effect (P>0.05) was seen between lipid content in embryos cultured in 
continuous or 3-step sequential media (33.78± 0.90 AFUs vs. 32.40± 1.00 AFUs, 
respectively) [Table 1]. This result held true when examining the interaction between stage 
and media type, as well as additives and media type [Table 1]. After it was determined 
that media type did not have an effect on lipid accumulation, this factor was removed from 
inclusion in further results analyses and a continuous media was then used for part 2 of 
this study.  
4.3.2 Stage of development (Part 1) 
 Late stage embryos had less (P<0.05) intracellular lipid accumulation than did 
early stage embryos in both the additive and the no additive groups. Early stage embryos 
had a mean lipid content of 43.81±1.62 AFUs when cultured with no additives, and a mean 
of 33.41±0.80 AFUs when cultured with additives [Fig. 8]. Late stage embryos had a mean 
lipid content of 31.33±1.80 AFUs when cultured with no additives and a mean of 
23.79±0.85 when cultured with additives [Fig. 8].  
4.3.3 Media additives (Parts 1 and 2) 
 For part 1, a combination of L-carnitine, CoQ, VitK, and forskolin decreased mean 
lipid content in both early (33.41±0.80 AFUs vs. 43.81±1.62 AFUs (no additive)) and late 
stage (23.79±0.85 vs. 31.33±1.80 AFUs (no additive)) embryos [Fig. 8&10]. Culturing 
embryos in the presence of additives reduced the lipid content of early stage embryos to 
be similar to the lipid content of late stage embryos cultured with no additives present [Fig. 
8]. For part 2, coenzyme Q10, vitamin K2, and forskolin all increased (P<0.05) mitochondrial 
polarity individually (5442±340.37 AFUs, 6288.6±299.55 AFUs, 6075.1±326.23 AFUs, 
respectively vs. 3351.6±328.12 AFUs (no additive)), however, these additives showed no 
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effect (P>0.05) when combined (3552.5±227.4 AFUs (all additives) vs. 3351.6±328.12 
AFUs (no additive)) [Fig. 9&10].  
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 Interaction Media Type N Nile Red AFUs SE 
a) 
None Continuous 149 33.78 ± 0.90 
None 3-Step Sequential 189 32.40 ± 1.00 
b) 
Early (6) Continuous 80 39.34 ± 1.17 
Early (6) 3-Step Sequential 101 37.88 ± 1.27 
Late (7) Continuous 69 28.21 ± 1.30 
Late (7) 3-Step Sequential 88 26.91 ± 1.35 
c) 
Additive Continuous 112 29.38 ± 0.90 
Additive 3-Step Sequential 163 27.82 ± 0.74 
No Additive Continuous 37 38.18 ± 1.56 
No Additive 3-Step Sequential 26 36.97 ± 1.86 
Table 1. Lipid content between groups. (Part 1) No difference (P>0.05) was seen 
between the mean lipid content of all embryos cultured in continuous media versus the 
mean lipid content of all embryos cultured in 3-step sequential media (a). No difference 
(P>0.05) was seen between early stage embryos or late stage embryos cultured in 
continuous versus 3-step sequential media (b). No difference (P>0.05) was seen between 
embryos cultured with additives or with no additives in continuous versus 3-step sequential 
media (c).  
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Figure 8. Lipid content between groups. (Part 1) Lipid content, as expressed by mean 
arbitrary fluorescent units (AFUs) of Nile Red in early stage embryos cultured with no 
additives (n=35), early stage embryos cultured with additives (n=146), late stage embryos 
with no additives (n=28), and late stage embryos with additives (n=129). Error bars 
represent standard error of the mean, and values without common labels differ (P<0.05). 
 
Stage: 
Additives:  -                   +                      -                       +    
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Figure 9. Mitochondrial polarity between groups. (Part 2) Mean mitochondrial polarity 
of embryos cultured in the presence of no additive (n=85), L-carnitine (n=91), coenzyme 
Q10 (n=79), vitamin K2 (102), forskolin (86), and a combination of all additives (177), as 
represented by arbitrary fluorescent units (AFUs) of MitoTracker Red. Error bars represent 
standard error of the mean, and values without common labels differ (P<0.05). 
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Figure 10. Representative images. Images showing intracellular lipid (Nile Red, green), 
nuclei (DAPI, blue), and mitochondrial polarity (MitoTracker Red, red). Stage 7 embryo 
cultured in the presence of additives (a) showing decreased intracellular lipids in 
comparison to a stage 7 embryo cultured with no additives (b). Stage 7 embryo cultured 
in the presence of vitamin K2 (c) showing increase mitochondrial polarity in comparison to 
a stage 7 embryo cultured with no additives (d). 
 
          
 
 
 
a) b) 
d) c) 
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4.4 Discussion  
 The changing nature of embryo physiology and nutrient requirements during 
preimplantation development certainly justify the concept of sequential media to provide 
the specific nutrients required at various stages (Gardner et al., 2000). There are several 
mechanisms that control nutrient uptake in the embryo, which include the concentration 
and availability of these nutrients in the embryo’s environment, as well as the regulation 
of enzymatic activity in response to this environment (Gardner et al., 2000). The latter is 
the most important way in which an embryo adapts to new surroundings (Gardner et al., 
2000). Altering the nutrient provision to the embryo throughout development may help to 
alleviate stress on the embryo through these adaptation mechanisms (Gardner et al., 
2000; Sutton-McDowall et al., 2012). However, while this sequential media system may 
provide the proper timing and ratio of exogenous energy sources, it does not facilitate the 
embryo’s metabolism of endogenous lipids (Sutton-McDowall et al., 2012).  
 There was a numerical but insignificant decrease in lipid accumulation seen in 
each category of embryos (early vs. late, additives vs. no additives) that were cultured in 
3-step sequential media as opposed to continuous media [Table 1]. This supports findings 
which indicate that improving nutrient supply may reduce accumulation of lipid droplets in 
bovine embryos (Abe et al., 2002). To see a significant change in lipid accumulation, 
however, the metabolism of these triglycerides must be facilitated. The groups of embryos 
cultured in the presence of additives exhibited a significant decrease in lipid accumulation 
at both the early and late stage of development. Forskolin activates adenylate cyclase on 
the membranes of cells, which increases intracellular cAMP and creates a signal cascade 
that ends in the activation of key lipase enzymes which control the breakdown of 
triglycerides into free fatty acids (Men et al., 2006). These free fatty acids require L-
carnitine for translocation into the mitochondria by carnitine palmitoyl transferase 1B 
(Sutton-McDowall et al., 2012). Providing L-carnitine as a β-oxidation cofactor in addition 
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to forskolin to generate free fatty acids for metabolism are likely the most significant 
effectors of the decrease in lipid accumulation seen in this portion of the experiment.  
Embryos utilize endogenous lipids as a source of energy throughout development, 
so it would follow that lipid accumulation decreases over time as these stores deplete, 
consistent with the findings in part 1 of this experiment examining the effect of stage on 
lipid accumulation (Abe et al., 2002; Jeong et al., 2009). However, there seems to be a 
disproportionately low utilization of these endogenous lipids in IVP embryos as compared 
to in vivo-produced embryos (Gad et al., 2012). While improper mitochondrial function 
may be a factor in this disproportionate lipid consumption, the morphology and functional 
efficiency of mitochondria at various stages of embryo development are only vaguely 
defined (B. D. Bavister & Squirrell, 2000). In this pilot study, it was found that a combination 
of all additives decreased lipid content in both early and late stage blastocysts.  
 Culturing embryos in the presence of CoQ and VitK alone resulted in an increase 
in mitochondrial polarity. This result was hypothesized, as both molecules work to 
transport electrons within the electron transport chain and facilitate the pumping of 
hydrogen ions across the inner mitochondrial membrane, generating a polar gradient 
(Baldoceda-Baldeon et al., 2014; Stojkovic et al., 1999; Vos et al., 2012). Forskolin was 
also found to increase mitochondrial polarity, which may occur by providing cells with free 
fatty acids from triglycerides that are available to undergo β-oxidation and subsequent 
metabolism (Men et al., 2006).  
Interestingly, both L-carnitine alone and a combination of all additives resulted in 
no change in mitochondrial polarity. With mitochondrial polarity being the only endpoint 
evaluated in part two of this study, there cannot be conclusive information noted regarding 
the reason for this occurrence. In part one of this study, a combination of all additives 
decreased lipid accumulation, showing a discrepancy between two of the endpoint 
markers of that are being used to evaluate the quality of these embryos.  
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As a result of this study, it is evident that looking at only lipid accumulation or 
mitochondrial polarity does not give an inclusive portrayal of the simultaneous 
mechanisms involved in embryo metabolism and lipid accumulation. The ultimate goal is 
to generate a culture system which produces cryotolerant embryos. To date, the markers 
for cryotolerance are lipid accumulation and ROS. Further studies should include 
development rate, lipid content, mitochondrial polarity, and cryopreservation survival to 
evaluate the effectiveness of each metabolic regulator when used alone or in combination 
with others, as well as improve the relevance of embryo quality markers used.  
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Chapter 5. Experiment 1: Metabolic Regulators and Cryopreservation 
5.1 Introduction  
 The particular manifestation of IVC artifacts lends insight into the causes and 
potential approaches for improvement in blastocyst quality. The most prominent of these 
artifacts are lipid accumulation, increased presence of ROS, and limited development 
rates (Abe et al., 2002; Absalón-Medina et al., 2014; Prastowo et al., 2016; M. Sudano et 
al., 2013; M. Takahashi et al., 2000). These effects are a result of a multitude of factors, 
however, a perturbed energy metabolism pathway, mitochondrial dysfunction, and the lack 
of a niche environment may be the forefront causes of the differences seen between in 
vitro- and in vivo-derived embryos (Abe et al., 2002; Chen et al., 1994; Gardner et al., 
2000; Prastowo et al., 2016).  
Cryopreservation is essential for the widespread use of IVP bovine embryos in the 
embryo transfer industry (Fair et al., 2001), and the success of this cryopreservation 
greatly depends on blastocyst quality (T. Takahashi et al., 2013). Intracellular lipid 
accumulation is highly correlated with cryotolerance, however, the mechanism by which 
lipids interfere with cryopreservation is still poorly understood (Abe et al., 2002; Barceló-
Fimbres & Seidel, 2007a; Seidel, 2006). What is known is that the conditions of in vitro 
culture seem to be the cause of this triglyceride accumulation, necessitating the 
optimization of IVC systems to improve blastocyst quality (Barceló-Fimbres & Seidel, 
2007a; Fair et al., 2001). Because of the correlation between blastocyst quality and 
cryotolerance, success rates of cryopreservation have been used and an indicator of 
embryo quality in studies of culture conditions (Rizos, 2002; Seidel, 2006) 
 A preliminary pilot study indicated that supplementation of embryo culture media 
with 30 μM coenzyme Q10 decreases lipid content [Fig. 6] but does not have an effect on 
mitochondrial polarity [Fig. 7]. However, a subsequent pilot study showed that both CoQ 
and vitamin K2 can increase mitochondrial polarity when used individually [Fig. 9]. 
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Because of the potential lengthening of the electron transport chain that can occur as a 
side effect of the delivery of CoQ in liposomal form (Schneider et al., 1982), it was decided 
that Vitamin K2 is a more optimal treatment for mitochondrial dysfunction. Vitamin K2 is 
believed to serve as an alternate electron carrier in a similar fashion as CoQ (Vos et al., 
2012). By increasing electron transport chain efficiency, Vitamin K2 can rescue cells from 
mitochondrial dysfunction (Vos et al., 2012).  
 Preliminary studies have also indicated that culturing embryos in the presence of 
L-carnitine and forskolin can decrease lipid content when compared to a control group 
[Fig. 8]. L-carnitine facilitates the action of CPT1B, which is the rate-limiting enzyme 
responsible for the transport of intracellular fatty acids into the mitochondria for 
metabolism (Sutton-McDowall et al., 2012). Forskolin may be able to work in conjunction 
with L-carnitine by providing the bioavailable free fatty acids to be metabolized. Forskolin 
activates adenylate cyclase, which creates a signal cascade that ends in the activation of 
hormone sensitive lipase, an enzyme responsible for cleaving the stores of intracellular 
triglycerides (Men et al., 2006).  
 Limited development rates are another inefficiency of in vitro culture. It is widely 
acknowledged that supplementation of embryo culture media with serum increases 
development relative to serum-free conditions (Absalón-Medina et al., 2014). However, 
the use of serum in culture media is also associated with lipid accumulation (Abe et al., 
2002; Barceló-Fimbres & Seidel, 2007b; E M Ferguson & Leese, 1999) and large offspring 
syndrome (Lazzari, 2002). Co-culturing embryos with a cellular monolayer is one 
approach to providing embryos with the beneficial growth factors found in serum, such as 
tissue growth factor β and insulin-like growth factor, without excess lipid supplementation 
(Abe et al., 2002). The cells within this monolayer secrete proteins into the media in which 
they are cultured, meaning this media can be removed from the cells and used to condition 
embryo culture media without adding the cells themselves (Chen et al., 1994). These 
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additional factors may promote continued growth by providing proteins, growth factors, 
and signaling factors that would normally be present in the oviduct and uterus but are not 
present in in vitro culture.  Vero cells are a cell line derived from Green monkey kidneys 
and are tested for viruses and other contaminants, making them a safe source for epithelial 
culture (Maeda et al., 1996).  
 The goal of improving bovine embryo culture is to generate embryos that are more 
similar in quality to in vivo-derived embryos, and to subsequently increase cryotolerance. 
The aim of the present study was to test the outcome of embryo culture with or without L-
carnitine, conditioned medium, VitK, forskolin, and all combinations of these additives, 
using cryopreservation survival as the ultimate marker of embryo quality. Development to 
the blastocyst stage, lipid accumulation, mitochondrial polarity, and percent of apoptotic 
cells after re-expansion will also be evaluated to provide insight into the quality of embryos 
in each treatment group.  
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5.2 Materials and methods  
5.2.1 In vitro embryo production  
 Embryos were produced from oocytes (n=1229, part 1; n=2461, part 2) as 
described in Chapter 2.2 with the following modifications.  
5.2.1.1 Addition of L-carnitine 
 A 50 mM stock of L-carnitine (C0283; Sigma) was prepared and stored at -80⁰C 
until the day of use. After fertilization, presumptive zygotes were randomly assigned to 
culture medium that contained either 0 mM L-carnitine or 0.5 mM L-carnitine and cultured 
for 7 to 9 days. 
5.2.1.2 Conditioned media  
 Vero cells (African Green Monkey kidney cells, Cercopithecus aethiops) were 
seeded in a four-well dish (Nunc, Copenhagen, Denmark) at a concentration of 1 x 105/mL 
using Tissue Culture Medium 199 (Life Technologies, Inc., Grand Island, NY, USA) 
supplemented with 5% fetal bovine serum. Cells were incubated at 37⁰C in humidified air 
containing 5% CO2 for 48 hrs. Conditioned media was aspirated from the wells, filtered, 
aliquoted, and frozen at -80⁰C until use. Conditioned media was added to culture media 
at a 5% v:v ratio, and embryos were randomly assigned to be cultured either in the 
presence or absence of conditioned medium starting at day 1 after IVF until stage 7 of 
development.  
5.2.1.3 Addition of vitamin K2 
 A 200 mM stock was prepared by dissolving vitamin K2 powder (V9378; Sigma) 
into 95.5% ethanol and freezing at -80⁰C. Vitamin K2 was added to randomly assigned 
embryo culture groups at day 3 after fertilization at a final concentration of 0.5 mM.  
5.2.1.4 Addition of forskolin 
 A 10 mM stock of forskolin was prepared by dissolving forskolin (344270; Sigma) 
into dimethyl sulfoxide solution and storing at -80⁰C. Forskolin was added to randomly 
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assigned embryo culture groups at a final concentration of 10 μM on day 5 after 
fertilization.  
5.2.2 Cryopreservation and thawing 
 Embryos were cryopreserved by standard slow freezing methods intended for 
direct transfer. Stage 7 blastocysts were equilibrated in 1.5 M ethylene glycol plus 0.5 M 
sucrose in holding media at 38.5⁰C for 10 minutes, then loaded into a 0.25 mL straw. 
Straws were cooled to room temperature during loading, then cooled to -6.5⁰C, seeded, 
and cooled at a rate of 0.3⁰C/min using a programmable freezer (Crysalys; IMV 
Technologies, Normandy, France). After completion of the freezing protocol, embryos 
were plunged into liquid nitrogen.  
 Straws were thawed in air for 10 seconds, in 32⁰C water for 30 seconds, then the 
embryos were expelled from the straw and passed through a series of wash media drops 
to remove all ethylene glycol and sucrose. After washing, embryos were placed into pre-
equilibrated embryo culture medium and placed back into culture for 36 hours. Post-thaw 
survival of embryos was assessed at 12, 24, and 36 hours of culture and recorded as a 
percentage of total embryos frozen per treatment group.  
5.2.3 Evaluation of embryos  
Development rates, lipid content, and mitochondrial polarity were evaluated as 
described in Chapter 2.3 with specifications as follows. Percent of apoptotic cells present 
in embryos after freezing and thawing was also used as an evaluation parameter.  
5.2.3.1 Lipid content 
 Lipid accumulation was quantified by staining stage 7 blastocysts with the lipophilic 
Nile Red dye as described in Chapter 2.3.2. Images were acquired by confocal microscopy 
at 40X magnification using an excitation/emission wavelength of 488/520 (Olympus 
Fluoview, Tokyo, Japan). Ten orthogonal projections along the equatorial section of the 
embryo were collected with a 5 μm step size. Fluorescence was measured using ImageJ 
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software (National Institutes of Health, Bethesda, MD, USA) with background fluorescence 
corrected for, and mean fluorescence between treatment groups was analyzed. Results 
are expressed in mean fluorescence arbitrary units (AFUs). 
5.2.3.2 Mitochondrial polarity  
 Mitochondrial polarity was assessed using MitoTracker Red CMX-rosamine dye, 
which binds with varying affinity based on degree of mitochondrial polarity, as described 
in Chapter 2.3.3. Images were acquired by confocal microscopy at 40X magnification 
using an excitation/emission wavelength of 594/608 (Olympus Fluoview, Tokyo, Japan). 
Ten orthogonal projections along the equatorial section of the embryo were collected with 
a 5 μm step size. Fluorescence intensity was measured using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA) with background fluorescence corrected for, and 
mean fluorescence between treatment groups was analyzed. Results are expressed in 
mean fluorescence intensity arbitrary units (AFUs). 
5.2.3.3 TUNEL assay 
Evaluation of apoptosis in frozen-thawed blastocysts was assessed by TUNEL 
assay (In Situ Cell Death Detection Kit, TMR Red; Roche, Basel, Switzerland). After 
cryopreservation and re-expansion of stage 7 blastocysts, surviving embryos were fixed 
in 10% paraformaldehyde (v:v) for at least 24 hours. TUNEL labelling was performed by 
washing the embryos three times in PBS-PVP, then treating with 0.5% (v:v) Triton X-100 
for 30 min at room temperature. Embryos were washed in PBS-PVP then incubated in a 
25 μL drop of TUNEL reaction mixture (containing enzyme solution and label solution in a 
1:9 (v:v) ratio)  for 1 hr at 38.5⁰C in humidified air, protected from light, according to the 
manufacturer’s instructions. Embryos were washed again in PBS-PVP and stained with 1 
μg/mL DAPI for 15 min at room temperature. As a positive control, embryos were treated 
with 1 IU/μL DNase (Promega Co., Madison, WI, USA), then incubated in a 25 μL drop of 
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reaction mixture as normal. As a negative control, embryos were incubated in a 25 μL 
drop containing only the marking solution.  
Finally, embryos were washed in PBS-PVP and mounted in a 1:10 (v:v) dilution of 
ProLong Diamond Antifade Mountant (ThermoFisher Scientific, Waltham, MA, USA) in 
PBS for imaging. Images were acquired by confocal microscopy at an excitation/emission 
wavelength of 594/608 for the TUNEL channel and 350/470 for the DAPI channel. Ten 
orthogonal projections along the equatorial section of the embryo were collected with a 5 
μm step size. TUNEL and DAPI channels were overlain using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA) and cells with overlapping nucleus staining were 
counted as TUNEL positive. Total cell number was calculated using a cell counter plug-in 
through the ImageJ software, and percentage of apoptotic cells was calculated as the 
number of TUNEL positive cells divided by the number of total cells counted.  
5.2.4 Experimental design 
 This experiment was separated into two parts. In part 1, a 2 x 2 factorial design 
was used to compare the effects of conditioned medium (0% vs. 5% at day 1 after IVF) 
and L-carnitine (0 mM vs. 0.5 mM at day 1 after IVF). Blastocyst rate, lipid content, 
mitochondrial polarity, cryopreservation survival rate, and percentage of apoptotic cells 
after re-expansion were used to evaluate embryos from each treatment group. The 
experiment was performed in 8 replicates with cryopreservation performed in 6.  
 For part 2, a 2 x 2 x 2 factorial design was used to compare the effects of 
conditioned medium (0% vs. 5% at day 1), vitamin K2 (0 mM vs. 0.5 mM at day 3), and 
forskolin (0 μM vs. 10 μM at day 5). L-carnitine was held as a constant factor in part 2, 
and was present at a concentration of 0.5 mM at day 1 after IVF in all treatments. 
Blastocyst rate, lipid content, mitochondrial polarity, cryopreservation survival rate, and 
percentage of apoptotic cells after re-expansion were used to evaluate embryos from each 
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treatment group. The experiment was performed in 8 replicates with cryopreservation 
performed in 4. 
5.2.5 Statistical analysis  
 Data for blastocyst rate, re-expansion rate after cryopreservation, and percentage 
of apoptotic cells after re-expansion were transformed by the arcsine method 
(arcsin(SQRT(x/100)) then evaluated by factorial ANOVA to determine if interactions exist 
between treatment groups. If no interaction was present, data was analyzed by one-way 
ANOVA. Means were separated by LSD if the ANOVA was significant (P<0.05). Data for 
lipid content and mitochondrial polarity was also evaluated by factorial ANOVA first, then 
one-way ANOVA if no interactions were present. Means were separated by LSD if the 
ANOVA was significant (P<0.05). Analysis was performed using the SAS statistical 
software package general linear model (GLM; SAS Institute, Cary, NC, USA).  
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5.3 Results 
5.3.1 L-carnitine and conditioned medium (Part 1) 
 No difference (P>0.05) was seen in blastocyst rates between treatment groups 
[Fig. 11]. Lipid content was reduced (P<0.05) in embryos cultured in the presence of L-
carnitine (266.43 ± 14.44 AFUs, control vs. 214.78 ± 13.85 AFUs, L-carnitine) [Fig. 12], 
which coincided with an increase (P<0.05) in cryopreservation survival (42.02 ± 9.46%, 
control vs. 72.32 ± 9.46%, L-carnitine) [Fig. 14]. There was no difference (P<0.05) in 
mitochondrial polarity between the control and L-carnitine treatment groups (6039.4 ± 
279.89 AFUs vs. 5530 ± 265.53 AFUs, respectively), while embryos cultured in 
conditioned media had decreased (P<0.05) mitochondrial polarity (4826.4 ± 265.53 AFUs) 
[Fig. 13]. Embryos cultured with L-carnitine plus conditioned medium showed an increase 
(P<0.05) in mitochondrial polarity (7210.1 ± 289 AFUs) [Fig. 13]. Finally, there was no 
difference (P>0.05) observed in the percentage of apoptotic cells between re-expanded 
embryos in any treatment group [Fig. 15].  
5.3.2 Vitamin K2, forskolin, and conditioned medium (Part 2) 
 After holding L-carnitine as a constant factor, embryos cultured with conditioned 
medium, vitamin K2, and forskolin combined showed an increase (P>0.05) in blastocyst 
rate compared to the control (39.4 ± 2.38% vs. 31.45 ± 2.83%, respectively) [Fig. 16]. Lipid 
content was reduced (P<0.05) in embryos cultured with only VitK, only forskolin, VitK + 
forskolin, conditioned medium + forskolin, and CM + VitK + forskolin (173.43 ± 10.61 
AFUs, 149.49 ± 9.72 AFUs, 143.11 ± 10.61 AFUs, 185.29 ± 9.97 AFUs, and 162.33 ± 9.43 
AFUs, respectively) compared to the control (214.78 ± 9.86 AFUs) [Fig. 17]. Lipid content 
increased (P<0.05) in embryos cultured with only conditioned medium (260.93 ± 10.28 
AFUs) and was no different (P>0.05) in embryos cultured with CM + VitK (225.83 ± 9.97 
AFUs) compared to the control (214.78 ± 9.86 AFUs) [Fig. 17]. Mitochondrial polarity 
increased (P<0.05) in the CM treatment group (7210.1 ± 248.14 AFUs), decreased 
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(P<0.05) in the VitK + forskolin (3716.4 ± 248.14 AFUs), CM + forskolin (4087.1 ± 235.41 
AFUs), and CM + VitK + forskolin (4810.1 ±263.19 AFUs) treatment groups, and showed 
no difference (P>0.05) in the rest of the treatment groups compared to the control (5530 
±235.41 AFUs) [Fig. 18].  
 Cryopreservation survival increased (P<0.05) in embryos cultured in the presence 
of VitK + forskolin (97.5 ± 9.18%) compared to the control (78.79 ± 9.18%) and decreased 
(P<0.05) in embryos cultured in the presence of conditioned medium (54.45 ± 9.18%) [Fig. 
19]. The percentage of apoptotic cells present in re-expanded embryos decreased in 
embryos cultured with VitK + forskolin (10.42 ± 2.55%) compared to the control (20.20 ± 
2.73%) [Fig. 20].  
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Figure 11. Blastocyst rate (Part 1). Blastocyst development rates between treatment 
groups did not differ (P>0.05). Error bars represent standard error of the mean. N=8 
replicates. CM = conditioned media. 
 
 
 
 
 
 
 
 
 
L-Carnitine:                 -                     +                      -                     + 
CM:                             -                      -                      +                    + 
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Figure 12. Lipid content (Part 1). Lipid content, as expressed by mean arbitrary 
fluorescent units (AFUs) of Nile Red, was decreased in embryos cultured in the presence 
of L-carnitine (n=174) compared to the control (n=160), but did not change in the presence 
of conditioned medium (CM) (n=180) or L-carnitine plus CM (n=160). Error bars represent 
standard error of the mean, and values without common labels differ (P<0.05). 
 
 
 
L-Carnitine:                 -                     +                    -                     + 
CM:                             -                      -                    +                    + 
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Figure 13. Mitochondrial polarity (Part 1). Mitochondrial polarity, as expressed by mean 
AFUs of MitoTracker Red was decreased in embryos cultured in conditioned medium (CM) 
(n=200) compared to the control (n=180), and increased in embryos cultured in L-carnitine 
plus CM (n=180). No difference was observed in embryos cultured with L-carnitine 
(n=200). Error bars represent standard error of the mean, and values without common 
labels differ (P<0.05). 
 
 
 
L-Carnitine:                 -                     +                    -                    + 
CM:                             -                      -                    +                   + 
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Figure 14. Re-expansion rate (Part 1). Post-thaw re-expansion rate was improved in 
embryos cultured in the presence of L-carnitine. N=6 replicates. Error bars represent 
standard error of the mean, and values without common labels differ (P<0.05). CM = 
conditioned media. 
 
 
 
 
L-Carnitine:                 -                     +                     -                      + 
CM:                             -                      -                     +                     + 
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Figure 15. Percent apoptotic cells (Part 1). No difference (P>0.05) was seen in the 
percentage of apoptotic cells after re-expansion between the control (n=25), L-carnitine 
(n=33), CM (n=22), and L-carnitine + CM (n=30) treatment groups. Error bars represent 
standard error of the mean. CM = conditioned media. 
 
 
L-Carnitine:                 -                        +                       -                        + 
CM:                             -                         -                       +                       + 
70 
 
 
 
 
Figure 16. Blastocyst rate (Part 2). Blastocyst development rates between treatment 
groups. Values without common labels differ (P>0.05). N=8 replicates. Error bars 
represent standard error of the mean. CM = conditioned media, VitK = vitamin K2. 
 
 
 
 
 
 
CM:                -           +            -            -            -           +           +           + 
VitK:               -           -             +           -            +          +           -            + 
Forskolin:     -           -             -           +            +          -            +           +  
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Figure 17. Lipid content (Part 2). Lipid content, as expressed by mean arbitrary 
fluorescent units (AFUs) of Nile Red, was decreased in vitamin K2 (VitK) (n=150), forskolin 
(n=179), VitK + forskolin (n=150), conditioned medium (CM) + forskolin (n=170), and CM 
+ VitK + forskolin (190) treatment groups compared to the control (n=174). No difference 
was observed in embryos cultured with CM + VitK (n=170), and lipid content increased in 
the CM (n=160) treatment group. Error bars represent standard error of the mean, and 
values without common labels differ (P<0.05). 
CM:                -           +            -           -            -           +           +           + 
VitK:               -           -             +          -            +          +           -            + 
Forskolin:     -           -             -          +            +          -            +           +  
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Figure 18. Mitochondrial polarity (Part 2). Mitochondrial polarity, as expressed by mean 
AFUs of MitoTracker Red was increased in the conditioned media (CM) (n=180) treatment 
group and decreased in vitamin K2 (VitK) + forskolin (n=180), CM + forskolin (n=200), and 
CM + VitK + forskolin (n=160) treatment groups compared to the control (n=200). No 
difference in mitochondrial polarity was observed in the VitK (n=190), forskolin (n=160), 
or CM + VitK (n=190) treatment groups. Error bars represent standard error of the mean, 
and values without common labels differ (P<0.05). 
CM:                -           +            -          -           -           +           +          + 
VitK:               -           -             +         -           +          +           -           + 
Forskolin:     -           -             -         +           +          -            +          +  
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Figure 19. Re-expansion rate (Part 2). Post-thaw re-expansion rate was improved in 
embryos cultured in the presence of vitamin K2 and forskolin. N=4 replicates. Error bars 
represent standard error of the mean, and values without common labels differ (P<0.05). 
CM = conditioned media, VitK = vitamin K2. 
 
CM:                -           +            -           -            -           +           +           + 
VitK:               -           -             +          -            +          +           -            + 
Forskolin:     -           -             -          +            +          -            +           +  
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Figure 20. Percent apoptotic cells (Part 2). The percentage of apoptotic cells after re-
expansion was decreased in embryos cultured with vitamin K2 (VitK) + forskolin (n=38) 
compared to the control (n=33). No difference was observed in the conditioned media 
(CM) (n=30), VitK (n=40), forskolin (n=37), CM + VitK (n=47), CM + forskolin (n=36), or 
CM + VitK + forskolin (n=53) treatment groups. Error bars represent standard error of the 
mean, and values without common labels differ (P<0.05). 
 
 
 
 
 
CM:                -           +            -            -             -            +           +           + 
VitK:               -           -             +           -             +           +           -            + 
Forskolin:     -           -             -           +             +           -            +           +  
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       No Additive           L-carnitine + CM + VitK + Forskolin 
  
  
  
Figure 21. Representative images (Part 2). Images showing intracellular lipid (a-b) (Nile 
Red, green), mitochondrial polarity (c-d) (MitoTracker Red, red), and apoptotic cells (e-f) 
(TUNEL assay, red). In all images, nuclei are stained with DAPI (blue). Apoptotic cells are 
represented by an overlap of DAPI and TUNEL (e-f). Embryos in the left column of images 
were cultured with no additives (part 1), and embryos in the right column were cultured in 
the presence of all additives (L-carnitine + conditioned medium (CM) + vitamkin K2 (VitK) 
+ forskolin). 
a) b) 
c) d) 
e) f) 
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5.4 Discussion 
Mitochondrial dysfunction, increased cytoplasmic lipid accumulation, and elevated 
levels of reactive oxygen species have been described as the “fateful triad” of effects 
associated with bovine embryo in vitro culture (Prastowo et al., 2016). The cause, 
sequence, and interaction of these effects are poorly understood, however. As the embryo 
progresses through various stages of development, the functional role of mitochondria 
changes and these organelles mature (Houghton & Leese, 2004; Tarazona et al., 2006; 
Jeremy G Thompson et al., 1996). Additionally, gene expression, enzyme activation, and 
energy demand are rapidly changing mechanisms within the preimplantation embryo 
(Gardner et al., 2000; Houghton & Leese, 2004; H. J. Leese, 2012), lending complexity to 
the study of metabolic needs (Absalón-Medina et al., 2014). While it may be true that the 
embryo has a great deal of plasticity, the sweep of molecular events which follow a stress-
induced reaction of the embryo to its environment can lead to abnormal fetal growth, 
modified placentation, and even abortion after transfer (H. J. Leese, 2012; J G Thompson, 
Kind, Roberts, Robertson, & al, 2002). This highlights the significance and impact of 
generating a culture system which mimics the in vivo environment as closely as possible.  
In part one of this experiment, L-carnitine reduced lipid content and improved post-
thaw re-expansion [Fig. 12-14]. The physiological role of this substance in transporting 
fatty acids across the inner mitochondrial membrane for β-oxidation and ATP production 
explains the reduction in lipid accumulation. Reduced intracellular lipid is associated with 
improved cryotolerance, which is consistent with the trend seen here. L-carnitine is also 
thought to act as an antioxidant by protecting the key enzymes involved in the cell’s 
antioxidant defense system from peroxidative damage (Abdelrazik, Sharma, Mahfouz, & 
Agarwa, 2009; Gülçin, 2006), which may add to the reason for improved cryotolerance 
observed. L-carnitine was kept as a constant factor for part two of this experiment because 
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of the significant positive effect on cryopreservation seen and the well-explained 
mechanism of action to support the observations seen.   
 Complexity arises from the use of multiple metabolic regulators in parallel. While 
vitamin K2 and L-carnitine work through mechanisms focused within one part of the cell, 
the activation of adenylate cyclase by forskolin and the stimulation by growth factors from 
conditioned medium are non-specific mechanisms that can have an array of effects. 
Furthermore, when these media additives are combined, the interworking of their 
downstream pathways is unknown. For this reason, cryopreservation was chosen as the 
most relevant endpoint marker of embryo competence, supplemented by data regarding 
intracellular lipid content, mitochondrial polarity, blastocyst rates, and apoptotic cell 
percentage.  
An interesting result was observed in the mitochondrial polarity of treatment groups 
in this experiment. After holding L-carnitine as a factor present in all treatment groups, 
there was no increase in mitochondrial polarity when vitamkin K2, forskolin, or a 
combination of both was used. In fact, there was a decrease (P<0.05) in polarity with all 
three (VitK + forskolin + L-carnitine) additives present [Fig. 18]. A similar phenomenon 
was observed in Pilot Study 2, wherein VitK and forskolin each increased mitochondrial 
polarity when used individually, but the effect was lost when the additives were used in 
combination with L-carnitine [Fig. 9].  
A possible explanation for this is the presence of a feedback mechanism by which 
the mitochondrion can decrease activity in response to an excess of electron donors, or 
an accumulation of ATP (Prastowo et al., 2016). It is also possible that this feedback 
mechanism works through the activation of a transcription factor family known as hypoxia-
inducible factors, which are capable of dynamic responses to a variety of conditions and 
may be upregulated in response to the hypoxic environment in which embryos are cultured 
(Harvey, 2007). Alternatively, overwhelming the mitochondria by providing an excess of 
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fatty acids can result in an increase in ROS, which disturbs β-oxidation and reduces 
mitochondrial activity (Prastowo et al., 2016). The exact mechanism by which disturbed 
β-oxidation decreases mitochondrial activity is unknown, however (Prastowo et al., 2016).  
This effect was seen in treatment groups containing L-carnitine because this 
molecule is required for function of the rate-limiting enzyme in fatty acid metabolism: 
CPTIB (Sutton-McDowall et al., 2012). Increasing the presence of free fatty acids through 
forskolin supplementation, or mitochondrial efficiency through CoQ or VitK 
supplementation can only increase the function of the electron transport chain to a certain 
extent. Increasing the availability of a rate-limiting molecule may provide the 
mitochondrion with such an abundance of electron donating molecules that this feedback 
mechanism is activated and mitochondrial activity decreases.  
 Defining markers of superior embryo quality and developmental competence is a 
topic that is not widely agreed upon. When evaluating mitochondrial dysfunction, 
mitochondrial polarity has been used as a marker of electron transport chain function. 
Studies have interpreted a greater inner mitochondrial membrane potential as an 
indication of increased mitochondrial function and improved embryo viability (Baldoceda-
Baldeon et al., 2014). The validity of this marker has been questioned, however, as it has 
been suggested that mitochondria which are actively undergoing ATP synthesis would be 
experiencing a decrease in mitochondrial polarity (Diaz et al., 1999; Van Blerkom, 2004, 
2009). Additionally, mitochondrial polarity changes depending on the type of cell to cell 
interactions present (Van Blerkom, 2009). This trend can be seen by the formation of gap 
junctions during the blastocyst stage coinciding with a decrease in mitochondrial polarity 
(Van Blerkom, 2009).  
 As an alternate approach to this marker, perhaps it is not the activity of 
mitochondria that should be evaluated, but rather the efficiency. In this context, a more 
relevant mark of mitochondrial function may be ROS generation. High levels of ROS are 
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associated with improper oxidative phosphorylation, lipid accumulation, and decreased 
embryo viability (Dumollard et al., 2009; Houghton & Leese, 2004; Prastowo et al., 2016; 
M. Takahashi et al., 2000). Because ROS are a downstream effect of mitochondrial 
dysfunction and have a direct link to perturbations in cellular function (Prastowo et al., 
2016; Van Blerkom, 2009), measurement of ROS may be a better marker of mitochondrial 
function. The trend seen from this experiment supports this notion, as an increase in 
mitochondrial polarity did not correlate with an increase in cryotolerance [Fig. 13, 14, 17, 
&20]. 
 Adding to the doubt of using increased mitochondrial polarity as a marker of 
competence is the quiet embryo hypothesis. In this theory, embryos with a quieter 
metabolism are subject to fewer damages to the genome, transcriptome, and proteome of 
cells as a result of lower ROS generation (Henry J. Leese, 2002). It is believed that 
embryos under cellular stress require more ATP for cellular repair mechanisms than more 
competent embryos (H. J. Leese, 2012; Henry J. Leese, 2002).  
 It was found that a combination of L-carnitine, vitamin K2, and forskolin had the 
most positive effect on cryopreservation survival, however, conditioned medium provided 
an increase in the percentage of embryos reaching the blastocyst stage. Because 
cryotolerance was chosen as the ultimate marker for embryo quality, L-carnitine in 
combination with only vitamin K2 and forskolin was concluded to generate the most 
competent embryo. As testament to the quality of embryos in this treatment group, the 
percentage of apoptotic cells present in the re-expanded frozen embryos was decreased, 
indicating a superior ability of the cells within these embryos to withstand freezing. The 
rescue of cells from mitochondrial dysfunction can prevent apoptosis, which is the 
objective of using VitK in embryo culture (Baldoceda-Baldeon et al., 2014; Vos et al., 
2012). A reduced percentage of apoptotic cells as well as increased cryotolerance 
indicates a rescue of these embryos from mitochondrial dysfunction, suggesting a re-
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evaluation of the use of mitochondrial polarity on stage 7 blastocysts as a marker for 
embryo quality. L-carnitine, VitK, and forskolin are believed to work through various 
pathways which together help to mitigate the negative artifacts of in vitro culture. Future 
studies should more precisely evaluate the pathways of action of these metabolic 
regulators and investigate biologically relevant substitutes.  
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Chapter 6. Concluding Remarks  
This research contributes to the vast effort of understanding preimplantation 
embryo energy metabolism and developmental viability. While these studies lend insight 
into the effects of metabolic regulators during culture from the 1-cell to blastocyst stage, a 
major limitation of this research is that data collection stops in vitro. A more encompassing 
portrayal of the developmental competence of these embryos would involve trials followed 
through to the pregnancy and post-partum stages so that pregnancy rate and normalcy of 
offspring can be assessed. In fact, this seems to be a pitfall of most current data regarding 
embryo metabolism (H. J. Leese, 2012). For evaluating development, emphasis is 
typically placed on the percentage of embryos that reach the blastocyst stage rather than 
the normality of these cultured embryos (Barnett & Bavister, 1996).  
In the more immediate future, this research can be applied to the combination of 
an optimized culture system with an optimized cryopreservation method. Efforts have 
been focused on the improvement of in vitro culture conditions because the negative 
outcome of cryopreservation of IVP embryos results from the deviant qualities of these 
embryos in relation to in vivo derived embryos (Seidel, 2006). Modifying cryopreservation 
methods to fit the cells being cryopreserved will also improve cryopreservation outcome 
(Seidel, 2006). Additionally, the intrinsic quality of the oocyte is the main factor affecting 
blastocyst yield (Rizos, 2002). As such, studies combining improvement in oocyte 
maturation in vitro with embryo culture in vitro will advance the quality and cryotolerance 
of IVP embryos.  
Evaluating the normalcy of IVP embryos requires a thorough understanding of in 
vivo embryo metabolism as well as the molecular dialog between the embryo and the 
female reproductive tract, both of which are still lacking (H. J. Leese, 2012). Knowledge 
of embryo metabolism within the reproductive tract will allow for the utilization of more 
relevant and effective biomarkers of embryo health. An understanding of the molecular 
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dialog between the embryo and its niche environment will aid in the tracking and 
prevention of epigenetic changes that have long term developmental consequences. 
Ultimately, research such as this helps to improve the success of assisted reproductive 
technologies and advance breeding efficiency within the dairy industry.  
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